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ABSTRACT 
In rodents, the olfactory system detects and processes chemical signals in the 
environment providing long-range information that is necessary for survival. They rely 
on olfactory input for social interactions, food locating, migration, reproduction and 
alerting to the presence of predators. In this study, transcriptions of certain sexual 
differentiation related genes, programmed cell death (PCD) related genes, axon 
guidance molecules and their related genes, marker protein genes, neurotransmitters 
and receptor gene as well as a growth factor binding protein gene are studied in the 
olfactory bulb of female, male and neonatal TP-treated female rats at the age of 2, 5, 
10，15，20, 25, 30，and 45 days. Using the labeled 32P-dCTP incorporation and 
Phosphorimager technology, the expressions of the target genes are determined after 
the reverse transcription polymerase chain reaction (RT-PCR). Since the expression 
of the housekeeping gene, (3-actin is found to be affected by the age and treatment in 
this study, cDNA concentration in the RT products measured by OliGreen are used for 
the corrections of unequal amount of cDNA added into the PCR tubes. The sex-
differentiation related genes, androgen receptor (AR) and oligomycin sensitivity-
conferring protein (OSCP) gene, but not the estrogen receptor beta (ERp) and 
aromatase gene are weakly sex dependent only at certain age groups. Treatment 
effects are found in aromatase and OSCP gene. The PCD related gene bcl-2a and 
caspase 3 are age dependent. Significant treatment and interaction effects on bcl-2a 
gene indicate differential treatment effect among different age groups. Axon guidance 
molecule, semaphorin III and related genes show similar developmental profile. They 
are highly expressed during the early development stages and decrease to a relative 
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low level of transcription in the late development. They are age dependent. 
Treatment effects are found in the transcription of members of collapsin response 
mediator protein (CRMP) genes, i.e. CRMP-1, 3 & 4. Sex differences, however, can 
be found only in case of CRMP-1 & 3 genes. Differential treatment effects on 
different age groups are evidenced in all CRMP genes, sema III and neuropilin-1 
genes, but not the plexin-1 gene. As indices for immature and mature neurons 
respectively, growth associated protein (GAP-43) and olfactory marker protein (OMP) 
genes are transcripted reciprocally during the development of olfactory bulb. The 
transcription of G-protein a-subunit gene for olfactory signaling, G0if, is affected by 
the age, but its profile fluctuates. Among these three genes, only OMP gene shows 
treatment effect in transcription. The expression patterns of the neurotransmitter and 
receptor genes and insulin-like growth factor binding protein-2 (IGFBP-2) gene are 
found to be affected significantly by age. With the exception of substance P, all the 
others such as gonadotropin releasing hormone (GnRH), metabotropic glutamate 
receptor 2 (mGluR2) and IGFBP-2 show an increase of transcription in the early 
development but drop in the later development stages. No treatment and interaction 
effect can be found. 
Conclusively, the developmental profiles of gene transcriptions in the 
developing olfactory bulb provide a basis for design of further experiments in 
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1. Introduction 
1.1. Olfactory system 
In mammals, the olfactory system can be divided into peripheral and central 
component. The former is extracranial, represented by the olfactory epithelium within 
the nasal cavity, whereas the latter is intracranial and includes the olfactory bulb and 
various cortical and subcortical brain regions which have both direct and indirect 
connections with olfactory bulb neurons (Shipley and Reyes, 1992). 
1.1.1. Olfactory bulb (OB) 
In macrosmatic mammals (animals that rely on the sense of smell for survival), 
two subdivisions of the olfactory system namely the main and accessory olfactory 
systems are recognized. These two subdivisions are parallel, yet, in many ways, 
separate in their integration of specific odor types. For example, olfactory receptor 
neurons (ORNs) in the olfactory epithelium transduce mostly volatile odors and 
transmit this information to the main olfactory bulb (MOB). By contrast, other ORNs 
located in the vomeronasal organ are exposed to odors during the activation of a 
norepinephrine-activated pump. Axons of vomeronasal neurons project exclusively to 
the accessory olfactory bulb (AOB), located at the dorsocaudal limit of the MOB. The 
central connections of these MOB and AOB to higher-order olfactory structures are 
parallel but essentially non-overlapping. Indeed, the relative size of olfactory-related 
structures reflects the importance of olfaction to the animal. Thus the olfactory bulb in 
humans is relatively small compared to the rest of the brain, whereas the rat, which 
depends heavily on olfaction for survival, has a relatively large olfactory bulb (McLean 
and Shipley, 1992). 
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OB is an oval structure that lies on the ventral surface of each frontal lobe and 
dorsal to the cribriform plate of the ethmoid bone. The OB is made up of neurons, 
afferent and efferent fibers, astrocytes, microglia and blood vessels enveloped by a thin 
layer of pia-arachnoid cells. These cellular elements are arranged in layers, namely the 
olfactory nerve layer, the glomerular layer, the external plexiform layer, the mitral cell 
layer, the internal plexiform layer, which in its deepest portion contains myelinated 
fibers and the granule cell layer (Shipley and Reyes, 1992). 
There are two major neuronal groups in the OB, the mitral and tufted cells, 
which are second-order neurons, and the interneurons, represented by the 
juxtaglomerular and granule cells. The axons of olfactory receptor cells terminate 
exclusively in the golmeruli. The latter structures are formed by the terminal arbors of 
olfactory nerve fibers, and are surrounded by several classes of juxtaglomerular 
neurons, including external tufted cells, short axon cells and the periglomerular cells 
which receive synapses from olfactory nerve terminals. The glomeruli are richly 
invested by ramifications of olfactory nerve synaptic endings. Therefore, each 
glomerulus is comprised of axon terminals of several thousands olfactory cells, the 
dendritic arbors of mital, tufted and periglomerular cells and other juxtaglomerular 
neurons, and synaptic interactions among these elements are extensive (Pinching, 
1970). 
Deeper in the bulb, below the layer of mitral cells, is the second major class of 
interneurons, the granule cells. These neurons make extensive dendrodentritic 
synapses with the lateral or secondary dendrites of mitral and tufted cells in the 
external plexiform layer. Axons of the mitral and tufted cells constitute the primary 
output pathway of the olfactory (Scott et al. 1980). Thus, interneurons of the 
olfactory bulb influence bulbar output via excitatory or inhibitory modulation of mitral 
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and tufted cells. This modulation is organized into two distinct and largely separate 
levels. 
The lateral or secondary dendrites of mitral and tufted cells ramify exclusively 
in external plexiform layer of the bulb. These dendrites are not influenced by olfactory 
nerve terminals, juxtaglomerular cells or centrifugal afferents that terminate in the 
glomeruli, but rather by neural elements in deeper layers of the bulb. Chief among 
these elements are the dendrites of the granule cells whose cell bodies are located deep 
to the mitral cell layer and internal plexiform layer in the granule cell layer. The apical 
dendrites of granule cells pass through the internal plexiform layer and mitral cell layer, 
then ramify and contact the lateral dendrites of mitral and tufted cells to form 
dendrodendritic synapses (Price and Powell, 1970). 
In addition to dendrodentritic synapses between mitral and tufted cells and 
granule cells, the mitral and tufted cell dendrites may also be influenced by other axons 
that terminate in the external plexiform layer, including axons from higher olfactory 
cortical areas and subcortical structures (Luskin and Price 1983)，although it is not 
known whether mitral cell dendrites and the external plexiform layer are contacted 
directly or indirectly via centrifugal synapses onto granule cell dendrites or onto other 
interneurons scattered in the external plexiform layer. The functional circuitry of the 
olfactory bulb may be usefully considered from the perspective of mitral and tufted 
cells. These neurons receive direct sensory input from primary olfactory neurons and 
•relay' an output to higher olfactory structures (Shipley and Reyes, 1992). 
1.1.2. Accessory olfactory bulb (AOB) 
AOB has some similar structural features to the MOB, but is much smaller. It 
is located at the caudal-dorsal end of the MOB. The vomeronasal nerve transmits 
3 
information from the VNO to the glomeruli of the AOB. The glomerular layer is less 
distinct in the AOB than those in the MOB because the AOB glomeruli are fewer and 
smaller. In addition, the periglomerular cells are far less than in the MOB, with the 
result that the glomeruli are not so neatly delineated by a shell of cell bodies. The 
external plexiform layer of the AOB and the mitral cell layer are also less distinct than 
the corresponding layers of the MOB, mainly because the mitral cells of the AOB are 
multilayered and mixed in with external plexiform layer. The granule cell layer of the 
AOB, located deep to the lateral olfactory tract, contains the same small type of cell as 
in the MOB granule cell layer. There are several important anatomical differences 
between the AOB and the MOB that may reflect differences in processing of olfactory 
inputs. Nonetheless, the obvious differences in neurochemistry of periglomerular cells 
in the MOB and the AOB suggest that there are significant differences in the 
processing of olfactory information at the first level of synaptic transfer between the 
epithelium (olfactory or vomeronasal) and other central structures (McLean and 
Shipley，1992). 
The growth of the AOB is influenced by steroids produced by testes (Roos et 
al., 1988). The AOB in the male rat is significantly larger than that in the female, but if 
the male is castrated，the AOB development is decreased to the size of the female 
AOB. These findings in the AOB correlate well with sexual dimorphisms in other 
regions (e.g., hypothalamus nuclei) that are known to govern sexual behavior, have 
been found to be sexually dimorphic (see Arnold and Gorski，1984 for review), and 
receive direct or indirect protections from the AOB (Simerly et al., 1989). 
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1.2. Stem cells 
During embryogenesis, a single fertilized oocyte gives rise to a multicellular 
organism whose cells and tissues have adopted differentiated characteristics or fates to 
perform the specified functions of each organ of the body. This fabulous ability of an 
embryo to diversify and of certain adult tissues to regenerate throughout life is a direct 
contribution of stem cells. Stem cells have both the capacities to self-renew, that is, to 
divide and create additional stem cells, and also to differentiate along a specified 
molecular pathway. Embryonic stem cells are very totipotent, reserving the elite 
privileges of choosing among most if not all of the differentiation pathways that specify 
the animal. In contrast, stem cells that reside within an adult organ or tissue have more 
restricted options, often able to select a differentiation program from only a few 
possible pathways (Fuchs and Segre, 2000). The long-held belief that neurogenesis is 
restricted to the embryonic period had to be critically reconsidered when evidence was 
found that new neurons continue to be added to certain regions of the adult vertebrate 
brain. In adult mammals, evidence exists that small populations of neurons continue to 
be added to the OB and hippocampus. Mammalian brain develops as a tube containing 
a ventricular compartment filled with cerebral fluid. Dividing，uncommitted neural 
crest-derived cells reside initially in the luminal cell layer, or ventricular zone (VZ), and 
then as development proceeds, in the "subventricular zone" (SVZ) that forms beneath 
it. During the development, these cells give rise to astrocytes, oligodendrocytes and 
neurons that populate the OB. From a quantitative analysis showing that almost 15% 
of SVZ cells expressed one of the early neural markers, it was concluded that a 
sufficient number of stem cells might exist to support neurogenesis in the adult brain 
(Fuchs and segre, 2000). 
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This postnatal SVZ surrounding the lateral ventricles has long been recognized 
as a source of forebrain astrocytes and oligodendrocytes (Levison and Goldman, 
1993). It is not clear to what extent the SVZ can be subdivided into distinct regions 
along the anterior-posterior axis of the forebrain according to the types of cells that are 
generated at specific locations (Levison and Goldman, 1993; Luskin et al., 1993). 
While much of the forebrain SVZ overlies the lateral ventricle and lies below the 
corpus callosum, a specialized arm extends rostrally to form the subependymal zone in 
the middle of the olfactory bulb. Pervious studies suggested that this rostral extension 
of the rat postnatal SVZ contained progenitor cells for olfactory bulb interneurons 
(Altman, 1969). Subsequently, lineage tracing studies demonstrated that in the 
neonatal brain of rodents, an essentially pure population of neuronal progenitor cells in 
situated in the anterior extent of the SVZ, referred to as the SVZa (Luskin et al., 1993; 
Zigova et al., 1996). 
During the development of the mammalian nervous system, newborn neurons 
often migrate considerable distances to reach their final location (Luskin, 1993). One 
of the dramatic examples of long distance migration occurs during the postnatal 
development of the rodent OB (Luskin et al., 1993). Throughout life, SVZa-derived 
cells migrate several millimeters from the SVZa to the olfactory bulb along a tangential 
pathway known as the rostral migratory stream and ultimately differentiate into 
periglomerular and granule cell neurons (Menezes et al., 1995). SVZa cells, unlike 
most other populations of neural progenitors, continue to divide throughout life (Lois 
and Alvarez-Buylla, 1994)，providing a constant source of new interneurons for the 
OB. While the period of peak production of SVZa-derived olfactory bulb interneurons 
is during the first postnatal week (Law et al., 1999). The region of the SVZa is a 
highly proliferative population in the first two postnatal weeks (Bayer, 1983). Unlike 
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other forebrain neurons which withdraw from the cell cycle before the initiation of 
migration, SVZa-derived cells with a neuronal identity continue to divide in the rostral 
migratory stream while en route to the OB (Kishi, 1987; Menezes et al., 1995; Smith 
and Luskin, 1998). The cells arising in the anterior SVZ migrate through the rostral 
migratory stream to the olfactory bulb and become fully differentiated, postmitotic 
interneurons. 
As the cells undergo their migration to the OB they are confined to a 
stereotypical pathway that corresponds to an extension of the subventricular zone into 
the middle of the OB, This indicates that the SVZa-derived cells are obeying a set of 
unknown guidance cues that they encounter during their migration. Once the SVZa-
derived cells reach the center of the OB, they change their direction of migration and 
radially ascend into either the granule cell later or the glomerular layer. Diffusible 
chemoattractive or chemorepulsive molecules have recently been described that may 
serve to guide growing axons toward their target (Dodd and Schuchardt, 1995). From 
experiment, migration of olfactory interneuron precursors from their source SVZa to 
the bulb is unidirectional. It is found that semaphorin-III (sema III), a soluble factor 
isolated from brain that can repel axonal outgrowth and which is found in ventral spinal 
cord but not floor plate (Luo et al.，1993，1995; Messersmith et al, 1995)，does not 
affect SVZ cell migration. These finding suggest that the septal factor for cell 
migration is distinct from chemotropic factors previously described for axon outgrowth 
and that it may influence cell migration outside of the brain. 
Each brain region is assembled by the sequential generation of different types of 
neurons. Each type of neuron is being formed during a restricted period of 
development, with only some neurons in certain brain regions continually being 
produced during juvenile or even adult life. In adult mice, constitutively dividing cells 
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in the SVZ have the capacity to migrate a long distance and differentiate into specific 
types of interneurons in the olfactory bulb. Other olfactory bulb neurons, like mitral 
and tufted cells, are formed during a restricted period of embryonic development 
(Bayer, 1983). 
1.3. Sexual differentiation 
1.3.1. Sexual dimorphic olfactory system 
Olfaction plays an important role in mammalian reproduction. Chemical cues 
can affect reproductive physiology or directly evoke behaviors essential to 
reproduction. Olfactory stimuli emitted by many species of mammals modulate 
conspecifics' sexual, aggressive, and maternal behavior. Such responses to 
intraspecific chemical signals are often dimorphic; that is, they are seen only, or to a 
greater degree, in one sex (Dorries, 1992). 
Odors that mediate mammalian behavior are often referred to as pheromones. 
The concept of pheromones is used widely in referring to olfactory stimuli involved in 
chemical communication in mammals (Vandenbergh, 1983). 
Signaling pheromones mediate the expression of a wide variety of behaviors. 
Olfactory cues, often in combination with stimuli from other modalities, initiate 
attraction and investigatory behaviors in reproduction, as well as eliciting receptive 
postures in females and mounting or intromission in males (Singer et al.，1986). 
Olfactory involvement in sex-related territorial and aggressive behavior has also been 
reported. For example, male mice emit odors that promote aggression in other males, 
and females emit odors that deter aggression (Lee, 1976). 
Many olfactory stimuli are of much greater significance to one sex than to the 
other, or affect animals of different sexes or reproductive conditions differentially, 
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initiating specific behaviors or changes in physiology in one but not another. One 
might expect to find sexual dimorphism in the olfactory system that processes these 
stimuli and mediates such changes (Dorries, 1992). Nonvolatile molecules secreted by 
specialized epithelial glands in the urogenital tract and on the body's ventral surface 
provide signals between males and females of numerous rodents. These pheromones 
serve a variety of social functions, including the attraction of conspecifics prior to 
mating, delineation of territories, and communication between mother and young 
(Baum, 1999). 
In mammals, olfaction may include up to five different chemosensory systems, 
depending on the species (Meredith, 1983). Thus far，however only main and 
accessory /vomeronasal olfactory systems have been examined for sexual dimorphism 
in peripheral and central structures. While both the main olfactory and vomeronasal 
systems mediate responses to pheromones in mammals, it has been hypothesized, based 
on differences in both effective stimuli and central connections of these two systems 
that the functions of the main and accessory olfactory systems differ. For example, 
attraction to and investigation of odors may be mediated by the main olfactory system 
(Johnston, 1985)，and reception processing of primer pheromones may be the domain 
of the vomeronasal system (Meredith, 1983). 
Receptor cells from the main olfactory epithelium form synapses in the MOB, 
which has primary projections to numerous areas. These include the anterior olfactory 
nucleus, the nucleus of the lateral olfactory tract, the olfactory tubercle, the pyriform 
cortex, entorhinal cortex, and the anterior cortical and posterior cortical nuclei of the 
amygdala (Johnston, 1985). Receptor cells from the sensory epithelium of the 
vomeronasal organ synapse in the AOB. The AOB is an olfactory structure embedded 
in the dorsocaudal portion of the olfactory bulb, and it constitutes a neural microcircuit 
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in which the axons of the vomeronasal organ (VNO) bipolar neurones establish 
synapses with the mitral cells. (Segovia and Guillamon，1993). The primary 
projections of the AOB are much more restricted than those of the MOB: these include 
the nucleus of the accessory olfactory tract, the bed nucleus of the stria terminalis，and 
the medial amygdaloid nucleus and the posteromedial sector of the cortical amygdaloid 
nucleus (Scalia and Winans, 1976). 
Development and differentiation of several regions of the accessory olfactory 
pathway are reported to be under the control of sex steroids. Most of these differences 
are found between female and male as well as female and TP-treated female. These 
suggest that endogenous androgen levels during development or adulthood affect 
olfactory structures, and, more specifically, their volume and cell number, the larger 
olfactory structures in males may permit a greater sensitivity to or more complex 
processing of olfactory stimuli (Dorries, 1992). 
There are many hormone-dependent sex differences in the structure of the 
brain, and these structural differences presumable underlie the many differences in 
sexual behavior that have been observed. In reality, however, each sex has a particular 
balance of several hormones, although testosterone (T) does predominate in males and 
estrogen or progesterone in females. How do gonadal steroids exert permanent or 
transient actions on the brain? Steroids can act on neurons in at least two ways. One 
is the classical pathway involving sex steroid receptors that activate or inhibit specific 
genes upon binding to steroid. This is the mechanism presumed to mediate the 
organizational effects of hormones. The second way in which sex steroids act on 
neurons involves direct action of them on the cell membrane which is less well 
understood (Gorski, 2000). 
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As early as 1936，Pfeiffer presented evidence that there is a critical period 
during early postnatal pituitary hormone secretion can be influenced permanently by 
testicular hormone action. Now, we believe that there is a critical developmental 
period during which sexual differentiation of neural substrates proceeds irreversible 
under the influence of gonadal hormones. In the rat, this period starts a few days 
before birth and ends approximately 10 days after birth (see review by Doehler，1998). 
In rats there is a striking sex difference in a group of neurons called the sexually 
dimorphic nucleus of the preoptic area (SDN-POA). The volume of the nucleus is 
about five times larger in the male than in the female. Most of the differences in this 
nucleus are due to a greater number of neurons in the male. Sex differences have also 
been reported for the AOB，the male rat shows larger volume than the female (Segovia 
et al., 1984). Even the numbers of mitral (Valencia et al., 1986) and granule cells 
(Segovia et al., 1986) are much higher in the male than the female. 
How might this increase in numbers of neurons occur? Steroids are known to 
prevent programmed cell death by apoptosis. In female, number of ceils within the 
posterior component of the nucleus decreases significantly between postnatal days 4 
and 10. This decrease does not occur in intact males or in females given the sex-
reversing regime of T. Moreover, the incidence of apoptotic cell death within a 
subregion of the nucleus is greater and more prolonged in the female (Gorski，2000)二 
Neurons of the developing and adult mammalian central nervous system (CNS) 
possess intranuclear receptors for gonadal steroid hormones such as estrogens and 
androgens，as well as the enzymes required for their synthesis and metabolism. The 
gonadal steroids had been shown to exert profound developmental influences on the 
structural and functions organization of the CNS of both sexes and to maintain those 
functions in the adult. Exposure of the developing brain to testicular androgens or to 
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ovarian secretions actively promotes the permanent differentiation of sex differences in 
the endocrine and behavioral aspects of reproduction and in a broad spectrum of their 
behaviors and functions, including higher cortical or cognitive functions (Toran-
Allerand, 1984). 
The molecular mechanisms of steroid-induced structural and functional 
organization of the brain are still unknown. Evidence is accumulating that sex steroids 
act on the developing brain and promote growth of responsive neurons (Toran-
Allerand, 1984). Steroids may also influence neurotransmitter metabolism, neuronal 
conductivity and synaptic connectivity of developing neurons, which may lead to 
permanent changes in synaptic transmission and overall neuronal activity. 
A series of studies had been performed in order to test the perinatal influence 
of hormones and neurotransmitters on development and differentiation of the SDN-
POA (Gorski et al.，1978; Doehler et al., 1984). The pre- and postnatal treatment of 
rats with TP was shown to substitute fully for testicular activities in stimulating SDN-
POA development, but the prime candidates for the control of SDN-POA 
differentiation do not seem to be androgens as such, but rather estrogens (Doehler et 
a l , 1984，1986 ; Doehler, 1998). 
In fact, aromatization of T to estrogen is a prerequisite for masculinization. In 
rats, a-fetoprotein that binds estrogen but not testosterone is present in the blood and 
the SDN in high concentrations during the first several weeks of the postnatal life. 
This a-fetoprotein, binds physiological levels of plasma estrogen and sequesters this 
hormone, protecting the female's brain from exposure to this masculinizing hormone. 
In males, testicular T is not bound by a-fetoprotein and therefore can enter neurons, 
where it is aromatized to estrogen and exerts its masculinizing action. It is also 
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consistent with the view that the default developmental pathway of the brain is 
feminine (Gorski, 2000). 
As in non-neural androgen target tissues，T can act in the CNS either as the 
unchanged circulating hormone or through receptor systems specific for different T 
metabolites that are synthesized locally. Paradoxically, many of its actions depend on 
initial intraneuronal conversion by aromatase to E2, and the subsequent binding of E2 to 
high-affinity intranuclear ERs，located in neuronal subsets of the aromatase-rich 
septum/vertical and horizontal nuclei of the diagonal band, hypothalamus, preoptic 
area, cerebral cortex, hippocampus and amygdala, among others (Pfaff and Keiner， 
1973). 
1.3.2. Androgen receptor (AR) & estrogen receptor beta (ERp) 
The receptors for steroid hormones are proteins that exist exclusively in the cell 
nucleus. Each of these receptor proteins function as DNA-binding proteins and they 
regulate the expression of genes related to the biological response of the hormone in 
question (Norman and Litwack, 1997a). The AR has been shown to function, as other 
steroid receptors, as a transcriptional regulatory protein that is essential for male 
sexual differentiation and development (Norman and Litwack, 1997b). The two 
principal androgens present in target cells are testosterone (T) and 5a-
dihydrotestosterone (DHT). Both T and DHT are produced mainly by the testes and 
circulate in the blood, there is also peripheral target tissue conversion of T to DHT. 
Both T and DHT are potent activators of the androgen nuclear receptor. It is not yet 
clear whether T or DHT is the predominant initiator of gene transcriptions； although 
both androgens bind very effectively to the androgen nuclear receptor. Thus, the 
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mechanism by which two different steroid hormones bind to the same receptor but 
achieve different biological functions is not yet known (Norman and Litwack, 1997b). 
The ER, a member of the steroid receptor superfamily of DNA-binding 
proteins, is a important ligand-modulated, trans-acting regulator of gene expression 
(Evans, 1988). The ER gene is a highly conserved single copy gene and its 
transcription product represents a relatively rare message population (Green et al., 
1986). Following exposure to estrogen, the receptor becomes an activated complex 
and is believed to bind to chromatin acceptor sites. The interaction of this complex 
with specific nucleotide sequences, termed hormone response elements, which are 
close to steroid responsive genes, apparently alters transcriptional efficiency of 
hormone-inducible genes (Yamamoto, 1985)，regulating mRNA and protein synthesis 
in order to effect a cascade of protein/DNA interactions that ultimately will enhance or 
suppress expression of those genes (Toran-Allerand, 1991). 
The existence of steroid-dependent, cytological difference suggests that 
estrogen may influence the survival and differentiation of its target neurons and 
circuits. An early, steroid-induced, differential enhancement of the cellular constituents 
of neural circuits may profoundly alter their subsequent patterns of development 
through an entire cascade of interacting morphogenetic events that will ultimately 
influence the survival and differentiation of neurons involved in the ontogeny of 
steroid-dependent neural circuits may result in the genesis of the observed structural 
dimorphisms of the adult (Toran-Allerand, 1984). Such pervasive inductive effects， 
exerted by estrogen, early during neuronal differentiation, may well determine the 
structural and functional properties of target pathways in the adult. 
There is considerable evidence that growth-promoting and growth-inhibiting 
factors may be secreted in response to estrogen. One should also consider the 
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possibility that these interactions may also reflect other biological aspects such as 
influences on steroid or growth factor receptor expression, growth factor receptor 
exocytosis to the cell surface, or effects on receptors or on the processing of their 
precursors (DiAugustine et al., 1988). 
In 1986，the ER-encoding cDNAs were cloned from several species (Green et 
al.，1986), Since that time there has been the general acceptance that only one ER 
gene existed, as is also accepted for other steroid hormone receptors. At the end of 
1995，a novel estrogen receptor (ERp) was cloned from a rat prostate cDNA library 
(Kuiper et al., 1996). The ERp subtype protein is highly homologous to the so far 
known estrogen receptor protein (consequently ERa), particularly in the DNA-binding 
domain and in the ligand-binding domain (Kuiper and Gustafsson, 1997). The rat 
tissue distribution and/or the relative level of ERa and ERp-mRNA expression is quite 
different; there is moderate to high expression in uterus, testis, pituitary, ovary, kidney， 
epididymis, adrenal for ERa and prostate, ovary, lung, bladder, brain, testis for ERp 
(Kuiper and Gustafsson, 1997; Shughrue et at, 1997). Only ERp is expressed in rat 
OB and binding affinity of ERp to estrogen is just one-quarter to ERa (Kuiper, et al., 
1997). 
1.3.3. Aromatase 
Two enzymes transform androgen in the body. Aromatase, a P450 enzyme 
converts T to estradiol (E2)，and the 5a-reductase enzymes which irreversibly convert 
T to DHT. Alterations in function of either of these enzymes alter particular aspects of 
differentiation (Canick et al., 1984). 
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In mammals, high levels of neuronal aromatase activity occur perinatally in 
medial telencephalic and hypothalamic regions at the time of psychosexual and brain 
sexual differentiation. The activity of this enzyme is reduced 10-fold in the adulthood. 
Neurons in these brain regions expressing aromatase also express androgen receptors 
and estrogen receptors prenatally, when circulating testosterone masculinizes 
psychosexual function. 
The role of the aromatase in the sexual differentiation of the mammalian brain 
is well established at least in rodents. It has been known for many years that, during 
fetal development,. T secretion from the embryonic testes is necessary for a normal 
male phenotypic development and for the masculinization of the brain (MacLusky and 
Naflolin，1981). In the absent of this hormone, the CNS develops in a primarily female 
fashion. Since estrogens mimic androgen actions both on organizational and 
activational brain processes in the male (Shinoda, 1994), it is now generally accepted 
that conversion of T to E2 is a key step in the sexual differentiation of the brain 
towards the male patterns during the early development (Celotti et al., 1997). 
It is found that the aromatase activity is 4 times higher in the POA-anterior 
hypothalamus (POA-AH) of the developing mouse than those of the adult (Wozniak et 
al., 1992). Since estrogen is involved in sexual differentiation of the brain and 
behavior, the neonatal mouse brain may have a greater functional requirement for 
aromatization than the adult. 
Regulation of the brain aromatase is an important step in determining when 
estrogen is available to act on the differentiating brain neurons. There is a sex 
difference in neuronal estrogen formation in which the embryonic male hypothalamus 
has considerably higher aromatase activity than the female and a greater number of 
aromatase immunoreactive cells. This sex difference is present in the early stages of 
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brain development and is enhanced by androgen during the period immediately before 
birth; a period which coincides with endogenous testicular T secretion. The 
androgenic environment of the hypothalamus appears to be instrumental in determining 
sex differences in a network of aromatase-containing neurons which provide estrogen 
required for the differentiation of the male brain (Hutchison et al.，1994). 
It was found that a distinct sex difference in androgen-stimulated induction of 
aromatase mRNA in both the POA and medial basal hypothalamus (MBH), which 
corresponded to sex differences in enzyme activity. These results indicate that the 
regulation of aromatase gene expression in brain by androgens is sexually dimorphic in 
rats. The demonstration that males has a greater capacity for aromatization in the 
POA could explain, in part, why males are behaviorally more responsive to 
testosterone than females, especially with respect to behaviors that require 
aromatization for T to exert its action. The underling cause of the of the sex difference 
in aromatase induction appears to be related to gender differences in androgen 
responsiveness (Roselli et al., 1996)，which may be a sexually differentiated feature of 
the brain. Compared to females, males may have greater numbers of aromatase-
containing cells or greater amounts of aromatase-coupled AR per target cell. 
However, it is also suggested that the greater responsiveness of males to T is not 
entirely due to higher concentrations of ARs. An alternative hypothesis is that the 
coupling mechanism between ARs and aromatase gene transcription may differ 
quantitatively in males and females (Roselli, 1991). In summary, the hormonal 
regulation of aromatase activity is controlled predominantly at the level of aromatase 
mRNA expression. The mechanism controlling expression of aromatase mRNA and 
activity is sexually dimorphic and may be responsible, in part, for gender differences in 
neural responsiveness to androgens (Roselli et al., 1997). 
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1.3.4. Oligomycin sensitivity-conferring protein (OSCP) 
Earlier studies have identified OSCP, a subunit of proton FOFl-ATPase/ ATP 
synthase in the mitochondrial inner membranes, as a novel E2 binding protein. And 
data indicate that the ubiquitous mitochondrial FOFl-ATPase is a specific target site 
for E2 and related estrogenic compounds (Zheng and Ramirez, 1999a，b). 
Estrogens exert direct actions on a variety of cells such as neurons, vascular 
smooth muscle cells and osteoblasts by mechanisms independent from nuclear estrogen 
receptors, so-called non-genomic mechanisms (Moss et al., 1997). The detailed 
mechanisms of these actions are unclear at present time and there is a need to identify 
the estrogen targeting proteins responsible for these actions. 
It seems that both diethylstillbestrol and E2 binds OSCP. It identifying a novel 
mechanism for actions of estrogens, that is different from the classical estrogen 
receptor mechanism. However, the physiological role of OSCP is still a question. 
1.4. Programmed cell death (PCD) 
1.4.1. PCD in the olfactory development 
PCD plays a prominent role in the morphogenesis of various organs and is 
commonly observed during invagination or evagination of epithelia, seam formation 
and organ detachment (Saunders, 1966). The main type of PCD occurring in such 
morphogenetic processes is called apoptosis, which is characterized by DNA 
fragmentation in oligonucleosomal units, chromatin condensation, cytoplasmatic 
shrinkage, fragmentation of the cell in intact apoptotic bodies and phagocytosis of the 
cellular debris by nearby cells (Suzuki et al., 1996). During the development of the 
central and peripheral nervous tissues, PCD is an important process that controls 
neuronal and glial cell number and to match the size of the neuronal projection to the 
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size of the target. The most probable reason for neuronal death is competition, either 
for a limiting amount of target-derived trophic factors or for the establishment of 
synaptic contacts able to stimulate an activity-dependent survival pathway 
(Oppenheim, 1991). 
Primary olfactory receptor neurons (ORNs) in the olfactory epithelium (OE) of 
mammals are produced massively during fetal life and continuously, later on, in the 
postnatal period and in the adult. Nonetheless, the thickness of the adult OE remains 
constant, indicating that the continuous generation of new olfactory cells must be 
offset by ongoing cell death (Farbman，1990). The OE of vertebrates is a 
pseudostratified epithelium. It consists of three main cell types, i.e. ORNs, basal cells 
and the supporting non-neuronal cells. As in the developing central nervous system, 
neurogenesis in the olfactory system occurs in several distinct stages. The neural stem 
cells of the basal layer undergo asymmetric division to produce neuronal precursor 
cells and the neuronal precursor cells divide symmetrically to generate two 
undifferentiated immature neurons (Calof and Chikaraishi, 1989). As the immature 
neurons start to differentiate, they migrate away from the basal layer of the epithelium. 
Thus, newly generated cells are present close to the basal layer, while the oldest 
neurons are close to the surface of the epithelium. 
Pellier and Astic have shown a massive cell death in the rat OE early in the 
development. It is the result of apoptosis and non-lysosomal disintegration. This 
phenomenon was shown to take place in coincidence with the initial process of axon 
outgrowth and was proposed to facilitate the exit of newly growing fibres (Pellier and 
Astic, 1994). In that sense, PCD is important in creating necessary space for axonal 
growth and differentiation. In adult animals, the olfactory axons are restricted to the 
glomerular layer of the OB and never reach the deepest layers. And it is possible that 
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this transient pattern of exuberant projections is probably eliminated by PCD, when its 
role during development is over. 
Mahalik (1996) has shown that apoptotic cell death involves both OMP 
(mature)- and GAP-43 (immature)- positive cells in the OE of adult rodents. The 
immature ORNs are suggested to be the most likely cells that undergo apoptosis 
(Mahalik, 1996). It is assumed that proliferation of the basal cells provides a 
continuous supple of 'almost mature' neurons ready to establish functional synaptic 
contact with their target. According to this hypothesis, the death of a functioning, 
synaptically connected neuron would leave some postsynaptic space in the OB. This 
space could then be occupied immediately by an 'almost mature' neuron from cells of 
the same local epithelial region. On the basis of this model, 'almost mature' neurons 
would undergo PCD when-they cannot find a synaptic target (Voyron et al., 1999). 
The life history of all neurons consists of several discrete neurogenetic stages, 
i.e. induction, differentiation, proliferation, migration, and formation of axonal 
pathways and synaptic connections, which eventually confer a specific physiological 
function to each neuron. However, in many parts of the CNS and peripheral nervous 
system (PNS), roughly half of the neurons undergo an additional stage in which 
regression leading ultimately to death occurs. This relatively large loss of neurons is a 
common feature in many types of neurons, occurs in all vertebrates, and appears to 
have evolved as an adaptive mechanism during the development of nervous system 
(Oppenheim，1991). The general explanation for this phenomenon is that the survival 
of developing vertebrate neurons depends on specific neurotrophic factors secreted by 
the target cells that the neurons innervate. In addition, the developing neurons also 
require signals from the other neurons that innervate them, some require specific 
hormones, and some perhaps require signals from the neighboring glial cells as well 
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(Raff et al., 1993). Thus, the survival of neurons depends on a complex interplay of 
several factors, and any imbalance in these inputs may lead to cell death. The 
beneficial effect of this mechanism is that although many types of neurons are 
produced in excess, only a portion of them gets sufficient neurotrophic support for 
their survivals, and the rest die to facilitate appropriate neuron-target cell innervation. 
Apoptosis has been used to describe all forms of spontaneous cell death that 
exhibit certain morphological characteristics. Cells dying by apoptosis shrink in size, 
the nuclear chromatin becomes pyknotic and condenses against the nuclear membrane, 
while the cytoplasmic organelles remain intact. Eventually, the cytoplasm and nucleus 
break up into apoptotic bodies that are phagocytized by macrophages or by adjacent 
phagocytic cells. Cell death by apoptosis usually involves individual cells that are 
engulfed or phagocytized before they can release their cellular contents and induce 
inflammatory response in the adjacent tissue (Oppenheim, 1999). 
Apoptosis is now recognized as a normal feature during the development of the 
nervous system. Several apoptosis-inducing agents have been identified, i.e. lack of 
neurotrophic supply，neurotransmitter, neurotoxicants，modulators of protein 
phosphorylation and calcium homeostasis, DNA-damaging agents, oxidative stress, 
nitric oxide, and ceramides. The precise signaling cascade is still not fully established, 
and there are lacunae in many suggested pathways. However, it is certain that proteins 
of the Bcl-2 family are involved in the apoptotic pathway, and these protein in turn 
affect the processing of expression of cysteine-dependent aspartate directed protease 
(caspases) (Sastry and Rao, 2000). 
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1.4.2. Caspase 3 
During development of the nematode Caenorhabditis elegans, of the 1090 cells 
produced during the ontogenesis, precisely 131 undergo PCD. Genetic analysis has 
defined lineage-specific genes that are though to be involved in the tissue-specific 
signaling required for PCD. In addition, series of genes that appear to be involved in 
PCD in all cells have been identified. These include several genes whose products are 
for degradation of genomic DNA in the engulfed cells. Three genes involved further 
upstream in the cell death process were also identified as: ced-3, ced-4 and ced-9 (Ellis 
et al., 1991). Mutation of ced-3 or ced-4 abolishes the developmentally regulated 
PCD, permitting the cells to survive and differentiate into mature cells, often neurons. 
Conversely, mutation of ced-9 increases the number of cells undergoing PCD. 
Subsequent analysis has revealed that ced-9 encodes a homologue of the mammalian 
protein Bcl-2, a polypeptide that inhibits PCD in a variety of cell types, including 
neurons (Merry and Korsmeyer, 1997)，while the ced-3 gene encodes a cysteine 
protease which is equivalent to the mammalian caspase 3 (Yuan et al., 1993). At the 
present time, there are more than 10 known mammalian members of the caspases 
(Alnemri et al., 1996). 
Caspases are cysteine proteases that cleave proteins at specific aspartic acid 
residues, exist as zymogens, and are activated through self-cleavage (Thornberry and 
Lazebnik, 1998); some activate others, thus acting in a proteolytic cascade, eventually 
leading to the cell death (Nagata, 1997). 
Once the caspases are activated, a subset of the total cellular polypeptides is 
selectively degraded and the neurons are irreversibly committed to undergo apoptosis. 
The proteolytic process can have one of the following effects: (1) it can alter the 
assembly/disassembly properties of a structural protein; (2) it can result in inactivation 
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Of a particular enzyme or (3) it can result in constitutive activation of a normally tightly 
regulated enzyme activity (Mesner and Kaufmann, 1999). 
Caspase 3 was subsequently identified as the protease responsible for cleaving 
poly(ADP-ribose) polymerase (Tewari et al., 1995). Poly(ADP-ribose) polymerase is 
a nuclear enzyme involved in DNA repair and was one of the first cellular substrates 
shown to be cleaved in apoptotic cells. In addition to sharing the highest sequence 
similarity with CED-3，caspase 3 appears to be the most functional homology ofCED-
3. Caspase 3 null mice die at 1-3 weeks of age and their brain development is 
profoundly disturbed due to decreased apoptosis (Kuida et al., 1996). This suggests 
that caspase 3 plays a critical role in the execution of apoptosis during development, at 
least in cells of the CNS. 
1.4.3. B cell leukemia/ Lymphoma 2 (Bcl-2) 
Crippling of homeostasis by caspases is central to the apoptotic process. 
Recent studies have revealed that proteins of the Bcl-2 family, such as Bcl-2 and Bcl-
XL, serve as novel targets of these apoptotic protease. Thus, the fabled point-of-no-
return in cell death should perhaps be equated with reaching a certain threshold of 
activation of proteases and other effector molecules. The role of Bcl-2 family 
members is to regulate this 'apoptotic threshold', possible at the level of the 
mitochondrion (Fadeel et al., 1999). 
The products of the bcl-2 gene family are regulators of neuronal apoptosis and 
substitutes for the neurotrophic factors in primary neuronal cells, as well as in 
established neuronal cell lines (Garcia et al., 1992). The Bcl-2 protein is widely 
distributed in many parts of the CNS during embryonic development, but declines with 
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age. Transgenic mice that overexpressed human Bcl-2 protein in their neurons showed 
reduced apoptosis and hypertrophy of the nervous system (Farlie et al., 1995). During 
development of the brain in mice, the bcl-2a and bcl-2p mRNA levels were highest on 
embryonic day 15，some two to three times higher than adult levels, suggesting a role 
for Bcl-2 in neurogenesis (Abe-Dohmae et al., 1993). 
All members of the Bcl-2 family share conserved domains that facilitate the 
formation of homo- and hetero-dimers which can regulate their activity. As an 
example, Bax is able to associate with Bcl-2 under in vitro and in vivo conditions, and 
by virtue of this association, suppresses the ability of Bcl-2 to inhibit apoptosis (Oltvai 
et al., 1993). The ratio of anti-apoptotic to pro-apoptotic Bcl-2 family members is 
therefore one stage at which the decision between apoptosis induction or protection 
can be made (Oltvai and Korsmeyer, 1994). 
Recently, Bcl-2 has been shown to act as upstream proteins of caspases to 
prevent their activation in the mammalian apoptotic pathway (Srinivasan et al., 1996). 
This indicates that the inhibitory action of Bcl-2 on caspases activity is indirect. A 
primary role of Bcl-2 has been proposed to prevent the leakage of cytochrome c 
leakage from the mitochondrial intermembrane space during apoptosis, and amputate 
of caspase activation in the cytosol (Yang et al., 1997). Cytochrome c is a 
mitochondrial protein located in the intermembrane space that is involved in the 
respiratory chain and has recently been implicated in the apoptotic program. 
Cytochrome c has been shown to be released to the cytosol in cells undergo apoptosis, 
a process which is inhibited by Bcl-2 (Kluck et al., 1997). It is suggested that Bcl-2 
acts upstream of Cytochrome c to prevent its release from mitochondria. However the 
direct mechanisms of Bcl-2 inhibition of Cytochrome c release from mitochondria and 
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subsequent Cytochrome c mediated caspases activation are presently not known (Yang 
et al, 1997). 
However, the exact mechanism ofapoptosis, i.e., the cascade of events starting 
from the detection of the signal at the cell surface to the events that occur in the 
nucleus, has not been established yet. 
1.5. Axon guidance molecules 
1.5.1. Growth cone 
Many developmental processes contribute to establishing precise patterns of 
connections, but none is more important than the guidance of axons from their points 
of origin to their appropriate targets. Precise regulation of axonal growth is crucial for 
development, synapse formation, plasticity, and regeneration of the nervous system. 
Numerous studies have provided evidence that axonal growth and guidance is 
regulated by attractive and repulsive molecules present in the extracellular 
microenvironment of the growth cone (Giger et al., 1998). 
Approximately 100 years ago, growth cone was first described and identified as 
the key decision-making component in the elaboration of axonal pathways (Raper and 
Tessier-Lavigne，1999). An axon extending in tissue culture is flattened at its distal tip 
into a thin fan-shaped sheet with many long, very thin spikes radiating forward. This 
tip is termed the growth cone. The fan shaped sheets are called lamellipodia, and the 
spikes are called filopodia (Bovolenta and Mason, 1987). 
The fan-shaped growth cone can be further subdivided into distal and proximal 
regions that are easily distinguishable by their outward appearance and internal 
structure (Cheng and Reese, 1985). The distal region includes the filopodia and the 
outer rim of the lamellipodia (Lin et al., 1994). It is extremely thin. When examined 
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with the electron microscope, the filopodia is found to be filled with fibrillar actin (F-
actin) and few organelles. The proximal region of the growth cone is considerably 
thicker and is packed with mitochondria, endosomes, and stacks of multilaminated 
membrane-bound vesicles. Coated pits and clear vesicles are found in both the distal 
and proximal regions. The large number of mitochondria in the proximal region helps 
to provide the considerable energy consumed by the growth cone's constant 
movement. The stacks of membrane presumably provide an inventory of new 
membrane that will be added to the cell surface as the growth cone advances (Dai and 
Sheetz, 1995). The coated pits and endosomes suggest considerable recycling of 
membrane already incorporated into the surface. Polyribosomes that appear to 
incorporate tritiated amino acids into polypeptides have been seen in some growth 
cones, raising the possibility that the local synthesis of proteins may sometimes help to 
supply the growth cones' needs (Davis et al., 1992). 
1.5.2. Mechanisms of growth cone advance 
Growth cones advance by adhesion of the leading edge to a permissive 
substrate. This causes actin polymerization at the leading edge. At the same time, actin 
depolymerization at the rear of the growth cone causes proximal processes to shrink. 
Growth cone collapse occurs when adhesion does not occur at the leading edge and 
actin polymerization is not initiated. Growth cones crawl forward as they elaborate the 
axons trailing behind them, and their extension is controlled by guidance cues in their 
outside environment that direct the toward their appropriate targets. For a single 
growth cone to change its direction in response to an outside cue, the cue must be 
inhomogeneously distributed in the outside environment, and the cue must have a 
localized effect on the growth cone. Filopodia radiation out from the growth cone are 
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well situated to identify permissive substrata upon which additional growth can occur, 
or to report back to the growth cone the presence of attractants or repellents nearby 
(Raper and Tessier-Lavigne, 1999). 
The localized induction ofactin polymerization by an attractant could cause the 
leading edge to advance more rapidly in the direction of highest attractant 
concentrations. In a complementary way, the leading edge should fail to advance or 
might even withdraw from repellents that locally inhibit actin polymerization at the 
leading edge. It is important to point out that this guidance mechanism requires a 
specific receptor to be linked to an intracellular signaling system to activate the 
appropriate cellular responses. Many axons are guided to distant target fields in 
stepwise fashion. Guidance cues in particular segments of their pathways can be 
provided by guidepost cell or by others axons. Studies in the past decade have led to 
the view that axon guidance involves the coordinate action of four types of cues: short-
range cues and long-range cues, each of which can be either attractive or repellent 
(Raper and Tessier-Lavigne, 1999). 
Long-range chemorepulsion, was discovered only recently, but has already 
been implicated in three different types of guidance events. The first event is perhaps 
best thought of as a "push from behind"，in which a chemorepellent secreted by a 
group of cells located near neuronal cell bodies appears to ensure that axons head 
away from their cell bodies in the right direction. One example of this is the initial 
growth of olfactory tract axons away from the septum; cells in the septal region secrete 
a chemorepellent that seems to "push" these axons away (Pini，1993). In a second type 
of repulsion, growing axons are deflected away from a particular region that they 
should avoid (Tamada, et al., 1995). Finally, chemorepellents secreted by cells located 
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beyond an axon's target may create an inhibitory barrier that prevents the axon from 
overshooting the proper target (Fitzgerald, et al., 1993). 
1.5.3. Semaphorins 
The semaphorins comprise an expanding family of secreted and transmembrane 
glycoproteins, characterized by the presence in their extracellular portions of a 
"semaphorin" domain approximately 500 amino acids long (Luo et al., 1995; Puschel 
et al., 1995), several members of which exhibit chemorepulsive activity. There are as 
many as 30 semaphorins, which can be subdivided into at least 7 structurally distinct 
classes, have been identified in many animal species from worms to mammals (Isbister 
et al., 1999). The best-characterized family member, semaphorin III (sema 
III)/collapsin-l (coll-1), exerts a strong developmental, stage-dependent, repulsive 
effect on olfactory neurons and causes growth cone collapse of sensory growth cones 
in vivo (Luo et al., 1993). 
Comparing the expression pattern of sema III with the trajectories of sema III 
responsive axons suggests that in olfactory bulb, sema III prevents premature entry of 
sensory axons into their target and helps determine the final location of sensory 
terminations (Kobayashi et al., 1997). 
Axons in the olfactory nerve wait on the surface of the telencephalon before 
entering the developing olfactory bulb. Olfactory sensory epithelial axons grow 
through the mesenchyme between the epithelium and the telecephalon, turn anteriorly 
once they reach the telencephalon, and stop where the olfactory bulb will later 
differentiate. Although a small number of pioneer olfactory axons transiently penetrate 
into the telencephalon, the vast majority of olfactory axons accumulate for days 
outside the CNS without entering it. These fibers only enter the CNS as the 
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telencephalic vesicle begins to evaginate when the olfactory bulb starts to form. 
Olfactory nerve axons ultimately terminate in glomeruli located within a superficial 
layer of the bulb (Valverde et al., 1992; Gong and Shipley, 1995). 
Curiously, sema III is expressed not only in the developing nervous system but 
also in the adult nervous system (Luo et s i , 1993; Giger et al, 1996; Shepherd et al., 
1996). In view of the possibility that semaphorins might play a role in plasticity of 
synaptic contacts in the adult nervous system (Giger et al., 1998). 
In the OB, sema III mRNA is expressed in mitral, tufted and juxtaglomerular 
cells (Giger et al., 1998). What could be the significance of sema III expression in 
mature olfactory bulb neurons? An appealing possibility is that sema III synthesized by 
mitral and tufted cells is secreted by their dendrites into the glomerular neuropil and 
acts there as a stop signal for ingrowing axons of newly formed sensory olfactory 
neurons. The turnover of sensory olfactory neurons in the olfactory neuroepithelium 
continues throughout life (Brunjes and Frazer, 1986). The axons of newly generated 
olfactory neurons grow along the primary olfactory pathway, penetrate the cribriform 
plate, and subsequently enter the bulb, where they terminate in a structure termed 
"glomerulus" and synapse on dendrites of mitral and juxtaglomerular cells (Farbman, 
1990). Thus, sema III released from mitral and tufted cells may instruct primary 
olfactory axons that enter glomeruli of the bulb to cease growing and allow them to 
establish synaptic contacts. In addition，the expression of sema III in juxtaglomerular 
cells might contribute to the nonpermissive microenvironment for axonal growth at the 
edge of olfactory glomeruli. This would be consistent with previous observations 
suggesting that, in adult rodents, primary olfactory neurons cannot grow into the 
deeper extraglomerular layers of the olfactory bulb but are restricted to the glomerular 
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neuropil by a constitutively growth-inhibitory microenvironment (Gonzalez and Silver, 
1994; Holtmaat et al., 1995) 
Therefore, Semaphorins have been involved in the development and 
regeneration of other axonal connections of the olfactory system (Shepherd et al., 
1996； Pasterkamp et al., 1998). Sema III can induce the collapse of olfactory axonal 
growth cones (Kobayashi et al., 1997) and could serve as a stop signal for these axons, 
initially preventing them from invading the olfactory bulb (Giger et al., 1996). 
It has been shown that transcription of sema III is induced during neuronal 
apoptosis (Shirvan et al., 1999). This induction process precedes the time point of 
commitment of neurons to the death process. It is further indicated that sema III is not 
only induced but may have an active role in determining the fate of neurons that 
exposed to an oxidative stress-inducing apoptotic trigger. There are results 
demonstrate the correlation between the death-inducing activity and the repulsive 
activity on axonal growth cones of sema III. It is also suggested that both activities 
may be mediated by the same signaling pathway and substantiate the relevance of 
axonal signals in the determination of cell fate. The effective concentrations of this 
protein during neuronal embryogensis, where a subtle interplay between several axon 
guidance molecules may determine the fate of the growing axons, are still unknown. 
During maturation of the developing brain,�50% of its neurons are eliminated by PCD 
(Oppenheim, 1991; Naruse and Keino，1995; Jacobson et al., 1997). It is also not 
known whether axon guidance molecules with repulsive cues such as semaphorins are 
involved in the apoptotic process of the developing nervous system. And it is still 
unknown whether sema III molecules have an active role in determining cell survival 
during neuronal development through their repulsive action on axonal growth cones. 
(Shirvan et al., 1999) 
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1.5.4. Neuropilin 
Recently, the transmembrane protein neuropilin-1 was identified as a receptor 
for sema III (He and Tessier-Lavigne, 1997; Kolodkin et al., 1997). In the adult 
mouse, neuropilin-1 is indeed expressed by primary olfactory neurons (Kawakami et 
al., 1996). Together with the demonstration that embryonic primary olfactory neurons 
in the chick are sensitive to sema III (Kobayashi et al., 1997), this provides compelling 
evidence that the growth of primary olfactory neurons in adult rodents may be halted 
by a mechanism involving sema III-neuropilin-1 signaling. 
Neuropilin is a type I membrane protein that is highly conserved among 
vertebrates. Neuropilin protein is restrictively localized on growing axons and growth 
cones (Fujisawa et al., 1995). Neuropilin Is a molecule that can mediate cell adhesion 
by a heterophilic molecular interaction (Takagi et al., 1995) and can promote neurite 
outgrowth in vitro (Hirata et al., 1993). In Xenopus tadpoles, neuropilin is expressed 
in the olfactory axon subclasses and has been suggested to play a role in selective 
fasciculaton of axons (Satoda et al., 1995). It was shown that neuropilin is a sema III 
binding protein and mediates sema Ill-induced chemorepulsive signals to neurons (He 
and Tessier-Lavigne, 1997; Kolodkin et al., 1997). These results suggest that 
neuropilin is a receptor or a component of a receptor complex for sema Ill-induced 
repulsive and growth cone collapse signals to neurons. Neuropilin is a common 
component of a receptor complex for particular semaphorin family members. The 
cytoplasmic domain of neuropilin protein is highly conserved among vertebrate species 
(Takagi et al., 1991; Kolodkin et al., 1997) but lacks motifs that potentially participate 
in cytoplasmic signal transduction. Thus, one hypothesis is that neuropilin forms a 
complex with additional receptor molecule(s) that is specific for each semaphorin 
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member and propagates the semaphorin-induced signals into the intracellular signal 
transduction pathway. 
1.5.5. Plexin 
The receptor protein for semaphorins might not be a kind of neuropilin (de 
Castro et al., 1999). It has recently been shown that a transmembrane protein plexin 
family, is a receptor for a viral semaphorin (Comeau et al., 1998). In Drosophila， 
plexin A binds transmembrane semaphorins (Winberg et al., 1998). Whether plexins 
are receptors for other vertebrate-secreted or transmembrane semaphorins remains 
unknown (Fujisawa and Kitsukawa, 1998). 
1.5.6. Collapsin response mediator proteins (CRMPs) 
A small family of CRMP has recently been discovered (Wang and Strittmatter, 
1996). Experiments shown that CRMP-62 is an important component of the signal-
transduction cascade triggered by sema Ill-induced growth cone collapse (Goshima et 
al., 1995). 
All four genes are expressed exclusively in the nervous system and primarily 
during the development. Rat CRMP-2 is the most widely expressed CRMP within the 
nervous system. Rat CRMP-1 and CRMP-4 are expressed during discrete periods of 
neuronal development and are not found in the adult nervous system. Rat CRMP-3 
has a distinct distribution, being expressed transiently in the developing spinal cord and 
selectively in the postnatal cerebellum. The differential expression of these genes 
suggests that CRMPs may transduce signals from different semaphorins and that 
semaphorins may regulate the plasticity of the adult nervous system (Wang and 
Strittmatter, 1996). 
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Each of the CRMPs has a unique transcript and displays a distinct expression 
pattern during development. They are highly related with each another by sequence. 
Expression of one or more of four CRMPs enables neurons to respond to the diverse 
signals of the semaphorin gene family during the development. The four CRMPs are 
derived from separate genes. Each of the CRMP genes appears to produce one unique 
transcript. The existence of the CRMP gene family is that different isoforms of CRMP 
are associated with transduction of signals from different semaphorins. Or CRMPs 
couple to various intracellular events stimulated by separate semaphorins (Wang and 
Strittmatter, 1996). 
1.6. Olfactory marker proteins 
1.6.1. Marker proteins in olfactory receptor neurons (ORNs) 
The olfactory system is unique in the mammalian CNS as it is a site of 
continuing neurogenesis in adulthood, replenishing its neuronal cells from the mitotic 
basal cell layer. The factors controlling this process of neurogenesis, differentiation 
and continual reinnervation of the neuronal target tissue, the olfactory bulb, are 
beginning to be defined (Calof et al., 1996). The initial events of olfactory signal 
transduction occur in the sensory cilia of ORNs. The cell bodies of the sensory 
neurons lie at various levels in the epithelial layer, and mature cells extend dendrites to 
the ciliary surface and axons to their neuronal target cells in the olfactory bulb 
(Cunningham et al., 1999). 
ORNs die and are replaced by new, immature neurons arising from cells 
resident in the basal cell layer. Following globose basal cell mitosis, a daughter cell 
moves apically in the epithelium and develops a basally directed axon and an apical 
dendrite. The axon extends through the basement membrane and grows towards the 
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olfactory bulb. Final maturation takes place when the axon forms a synapse in the bulb, 
and the dendrite reaches the surface and develops cilia from its dendritic projection 
(Cunningham et al., 1999). Immature olfactory neurons express molecules implicated 
in neuronal differentiation and neurite outgrowth: the growth-associated protein GAP-
43. As these neurons mature, they form olfactory cilia (Leinders-Zufall et al., 1998) 
and initiate the expression of G0if, an a-subunit of heterotrimeric G-proteins involved 
in signal transduction of olfaction (Jones and Reed, 1989) and the olfactory marker 
protein (OMP) (Margolis, 1972). 
1.6.2. Growth associated protein (GAP-43) 
GAP-43 is a neuron-specific phosphoprotein whose expression is associated 
with neural development and synaptic plasticity. During development, GAP-43 is one 
of a small number of proteins that is expressed selectively in association with process 
outgrowth (Perrone-Bizzozero et al., 1986). Its synthesis and axonal transport persist 
at high levels throughout axogenesis and synaptogenesis, and then decline precipitously 
with the establishment of stable synaptic relationships (Perry et al., 1987). GAP-43 is 
conveyed in the rapid phase of axonal transport from the neuronal somata in which it is 
synthesized to the nerve terminals, where it is enriched in the membranes of growth 
cones and of developing synapses (Skene et al., 1986). 
Throughout the development of the rat brain, levels of GAP-43 are highest 
during the first postnatal week, a period when synaptic organization is still taking 
place, then fall by more than 90% over the next few weeks (Jacobson et al., 1986). 
The distribution of GAP-43 is a function of both the age of the animal and the 
maturational state of the olfactory receptor neurons. In newborn rats, GAP-43 is 
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present throughout the entire population of olfactory receptor neurons. In the neonatal 
rats, GAP-43 can be visualized throughout the population of olfactory receptors, 
including the cell bodies, dendritic knobs, proximal olfactory cilia, and axons of the 
receptor cells. Thus, at least in the olfactory system, the expression of this protein is 
not solely restricted to axonal processes and axon growth cones, as has been 
previously suggested but occurs in dendritic processes as well (Oestreicher and Gispen, 
1986). 
In immunohistochemistry study, the olfactory nerve bundles and the glomeruli 
in the olfactory bulb are intensely stained in neonatal rats (Verhaagen et al., 1989). 
Although GAP-43 is present in all olfactory neurons in neonatal animals, its 
distribution is progressively restricted to receptor neurons deep in the epithelium of 
young adult animals. Concurrently, the extent of GAP-43 staining declines in the axon 
bundles and in the glomerular layer in the olfactory bulb. The GAP-43-positive cells 
may be a population of cells held in reserve by the tissue for immediate response to 
replace cells lost as a result of environmental damage (Verhaagen et al., 1989). This is 
probably governed by signals that are produced in the target area or by glial cells in the 
nerve tracts (Doster et al., 1991). The intraneuronal pathway that regulates GAP-43 
gene expression is complex and elements in regulation of GAP-43 gene necessary for 
transcription are only beginning to be understood (Eggen et al., 1994). Evidence is 
emerging that transcription of GAP-43 gene can be regulated by both activators and 
repressors (Chiaramello et al., 1996). The olfactory neuroepithelium has been the 
subject of numerous studies addressing questions related to mechanisms operative in 
neuronal plasticity. This is largely due to the unique ability of the adult olfactory 
epithelium to generate new neurons from a population of precursor cells present in the 
basal cell layer of the neuroepithelium (Verhaagen et al., 1989). The concept of 
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continued turnover of receptor neurons derives from (1) the observation that a 
developmentally heterogeneous population of receptor neurons is present in adult 
animals, and (2) autoradiographic studies that have demonstrated that neuroblast-like 
cells in the basal cell layer of the epithelium of mature rodents incorporate H-
thymidine. These labeled cells progressively advance to more superficial regions of the 
epithelium to become mature receptor neurons, this process can be accentuated 
following surgical or chemical damage to the mature neurons, resulting in their death 
and subsequent replacement from the progenitor cell compartment. Another possibility 
would be that continued expression of GAP-43 causes accelerated axonal and dendritic 
growth, accompanied by a more rapid migration into the upper compartment of the 
epithelium (Costanzo and Graziadei, 1983). 
1.6.3. Is the expression of GAP-43 in rat OB sexually dimorphic? 
The results of recent studies indicate that steroid hormones modulate GAP-43 
mRNA in the adult rodent hypothalamus. And it is shown that GAP-43 mRNA levels 
in the medial preoptic area, bed nuclei of the stria terminalis and cerebral cortex are 
sexual dimorphic and modulated by changes in gonadal steroid hormone levels. The 
results further suggest that the differential regulation of GAP-43 mRNA by sex 
steroids in the male and female postnatal brain may influence the phenotype of 
forebrain neuronal circuitry and thereby determine the phenotype of adult neuronal 
function (Shughrue and Dorsa，1993). 
The finding that levels of GAP-43 mRNA positively correlated with the level of 
serum testosterone suggests that GAP-43 gene transcription is modulated by steroid 
hormones during brain development. Since GAP-43 and estrogen receptor are present 
in similar regions of the cerebral cortex, bed nucleus of the stria terminalis and medial 
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preoptic nucleus, testosterone modulation of GAP-43 may be an estrogen mediated 
event. It is similar with the SDN-POA which shows sexual dimorphism induced by the 
different local concentration of estrogen. Interestingly, GAP-43 mRNA was found to 
be concentrated in the SDN-POA region during postnatal life. Furthermore, the level 
of GAP-43 mRNA was higher in males than in females and was modulated by changes 
in gonadal steroid hormone levels. Whether the hormone-dependent changes in the 
size of the SDN-POA and intensity of GAP-43 mRNA hybridization signal are related 
is currently unknown (Shughrue and Dorsa, 1993). 
Morphological studies on the adult brain have detected a sex dimorphism in 
numbers of synapses in the preoptic area and basal hypothalamus. This difference is 
found to be determined by the gonadal steroid hormone milieu during early postnatal 
life (Matsumoto and Arai, 1986). Numbers of estrogen target cells in the early 
postnatal and late fetal preoptic area of the hypothalamus further suggest that estrogen 
may directly influence neurite outgrowth from target neurons during brain 
differentiation. Since the number and topography (Sibug et al., 1991) of estrogen 
receptors are similar in the male and female brain, a sex difference in neurite outgrowth 
may be determined by the differential exposure of estrogen receptors to estrogen. This 
exposure appears to be more prevalent in the male brain due to the absence of high 
affinity estrogen binding protein a-fetoprotein and active aromatization of testosterone 
to estrogen in the male brain. These findings suggest that the differential action of 
gonadal hormones, or their metabolites, may establish a sex dimorphism in GAP-43 
expression. This difference may be one of the factors involved in determining the 
phenotype of neuronal connections (Shughrue and Dorsa, 1993). 
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1.6.4. Olfactory marker protein (OMP) 
Comparison of expressions of GAP-43 and the OMP genes revealed a 
reciprocal fashion of transcription during postnatal development of the olfactory 
system. The region of the epithelium containing the GAP-43-positive cells is virtually 
devoid of OMP-positive neurons (Verhaagen et al., 1989). The observed reciprocal 
expression of GAP-43 and OMP during the development of the olfactory epithelium is 
consistent with the view that GAP-43 is a marker of ongoing neuronal growth, while 
OMP is an indicator of olfactory neuron maturity. 
OMP has been postulated to participate in odor detection/signal transduction in 
olfactory receptor neurons and to be mitogenic to ORN precursors (Buiakova et al., 
1996). Maturation of the olfactory neuroepithelium is paralleled by a progressive 
increase in the number of neurons containing the OMP (Margolis, 1988) and 
expressing olfactory cilia (Chuah et al., 1985). OMP is expressed almost exclusively in 
mature ORNs where it is the most abundant cytoplasmic protein. The onset of its 
expression correlates with the time when the olfactory neurons become functional, and 
its expression continues throughout their lifespan (Margolis, 1988). The spatial and 
temporal specificity of OMP expression implies that its regulation is tightly controlled 
by olfactory neuron-specific transcription mechanisms (Kudrycki et al., 1998). The 
temporal expression of OMP in individual cells, however, may lag somewhat behind 
that of the signaling proteins, which could mean that OMP is not directly involved in 
olfactory transduction (Menco et al., 1994). 
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1.6.5. Goif 
Biochemical and physiological studies suggest that olfactory signal-
transduction begins when odor molecules interact with specific odor receptors on 
olfactory neurons (Vassar et al., 1993). This interaction leads to activation of GTP-
binding proteins (G proteins) that link the odor receptors to effector enzymes. Two 
effector enzymes namely adenylyl cyclase (AC) and phospholipase C (PLC), have been 
identified as participants in the signaling cascades. Stimulation of effectors leads to 
production of cAMP or inositol triphosphate (IP3). Either or both of these, directly or 
indirectly, gate ion channels in the sensory cell membrane, eventually leading to a 
change in membrane potential (Menco et al., 1994). 
An olfactory specific a-subunit of G-protein has been characterized and 
evidence is presented suggesting that this G-protein, termed G0if, mediates olfaction 
which was first cloned on the basis of enriched expression in the olfactory system, is 
localized to the olfactory cilia. Messenger RNA that encodes G0if is expressed in 
olfactory neuroepithelium but not in six other tissues tested. Immunocytochemical 
analysis localizes G0if localizes to the sensory neurons，intense staining is observed 
along the epithelial surface and in the membrane-dense axon bundles, while the 
neuronal soma stain very weakly. These analyses indicated that Golf is localized to the 
sensory neurons and suggest that Golf may be enriched in the presumptive sensory 
structures of these neurons (Jones and Reed, 1989). 
In order for G0ifto play a role in olfaction it must not only be expressed in the 
sensory neurons but also fulfill at least two biochemical criteria. First, it must couple 
to odorant receptors, and second, it must be able to stimulate the formation ofcAMP 
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(Jones and Reed, 1989). Accordingly, biochemical studies of AC activity and 
measurements of cAMP formation in isolated olfactory cilia implicated a G-protein 
mediated increase in cAMP in olfactory transduction (Pace et al., 1985). The above 
data demonstrate that Golf is capable of stimulating AC activity as required for 
olfactory signal transduction. 
From immunochemical studies, the immunoreactivity of antibodies to G0if was 
restricted to the secondary olfactory cilia, indicated that G0if is more restricted to 
maturing and mature receptor cells (Menco et al., 1994). And it was suggested that 
G0if is the major stimulatory G-protein for more mature receptor cells that interact 
selectively with odors (Gesteland et al., 1982). 
1.7. Miscellaneous genes 
1.7.1. Substance P (SP) 
Neuropeptides are peptides reported in the CNS, which work as 
neurotransmitters (Brownstein, 1994). SP is one of the neuropeptides that widely 
distribute in the peripheral and central nervous systems (Cuello et al., 1982). 
Immunocytochemical studies revealed that SP-like immunoreactivity (SP-LI) is also 
localized in particular cell types of the anterior pituitary (Morel et al., 1982). 
Significant higher immunoreactive SP (irSP) in the anterior pituitary level is 
found to be related to neonatal exposure to testosterone. It is suggested that these 
neuropeptide systems are sexually differentiated in certain brain areas and may play a 
role in regulation of hypothalamic-pituitary-gonadal axis and/or steroid-dependent 
behavior (Abe-Dohmae et al., 1996). 
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The development of irSP in mouse vomeronasal organs has been investigated. 
In all stages，SP fibers were found only in the olfactory receptor-free epithelial area, 
but not in the neuroepithelium. SP is considered as a trophic factor for the 
development of the vomeronasal glands in the cavernous tissue. Considering the 
development of the SP fibers in the receptor-free epithelium and the cavernous tissue, 
they probably cause the vasodilation of the cavernous tissue via local axon reflexes. 
These structures may then act as a defense system, eliminating noxious stimulus 
substances sucked into the vomeronasal organ (Nagahara et al., 1995). 
1.7.2. Gonadotropin releasing hormone (GnRH) 
Anosmia (the ability to smell) and infertility (hypogonadism and sterile gonads) 
are found in the patients of Kallmann's syndrome (KS). A dysfunction involving smell 
and reproduction was originally described in 1856 by Maestre de San Juan, and 
Kallmann reported the first familial case in 1944 (see review by Rugarli and Ballabio, 
1997). Subsequent research works demonstrated that the olfactory receptor neurons 
and the GnRH neurons in the dysfunction share a common developmental origin-the 
olfactory placodes (Schwanzel-Fukuda and Pfaff，1989). 
Under normal development, the olfactory receptor neurons and pheromone 
receptor neurons, i.e. the primary sensory neurons for olfactory stimuli remain in the 
nasal cavity while their axons traverse the nasal septum to the developing brain. When 
they reach the brain，olfactory receptor axons induce formation of the OB, while the 
axons, pheromone receptor neurons grows caudally into the developing olfactory 
nucleus. On the other hand, GnRH neurons leave the nasal cavity and migrate into the 
developing telencephalon, following a route across the nasal septum similar to that 
taken by olfactory and pheromone receptor neuron axons. And then turn caudally, 
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perhaps in association with pheromone receptor neuron axons, toward the developing 
diencephalon (Wray, 1999). 
In patients suffering from KS, the development of these system is perturbed, 
both GnRH neurons and olfactory and pheromone receptor neuron axons migrate to 
the base of the cribiform plate but remain outside the brain. The KAL gene has been 
cloned and the deduced amino acid sequence of which suggested an extracellular 
matrix component with antiprotease and/or cell adhesion functions (Franco et al., 
1991). However, the KAL gene was expressed in brain by cells of the OB but not in 
cells in nasal regions. KAL is now proposed to have a role in the events regulating 
contact and maintenance of olfactory receptor axons within the OB. How the KAL 
protein affects movement of GnRH neurons into the brain is still unknown. The 
current hypothesis suggests that the anosmia observed in KS results from a CNS 
olfactory target cell defect (Wray, 1999). Because of this close relationship between 
the GnRH neurons and OB, we are interested in the gene expression of GnRH in rat 
OB. 
1.7.3. Metabotropic glutamate receptor 2 (mGluR2) 
During sexual intercourse, an olfactory memory of the male pheromones was 
formed in female mice. Exposure to the pheromones of a strange male after that 
mating will block pregnancy. The formation of this memory is mediated by the 
accessory olfactory system, in which an increase in norepinephrine after mating reduces 
inhibitory transmission of gamma-aminobutyric acid (GAB A) from the granule cells to 
the mitral cells. It is suggested that the activation of mGluR2, a metabotropic 
glutamate receptor that suppresses the GABA inhibition of the mitral cells, permits the 
formation of a specific olfactory memory without the occurrence of mating by infusion 
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of rnGluR2 agonists into the female's accessory olfactory bulb (Kaba et al., 1994). 
This memory faithfully reflects the memory formed at mating. 
Nakanishi and colleagues demonstrate that mGluR2 is present at the 
presynaptic site of granule cells and modulates inhibitory GABA transmission from 
granule cells to mitral cells. This finding indicates that the mGluR2 activation relieves 
excited mitral cells from GABA inhibition but maintains the lateral inhibition of 
unexcited mitral cells, thus resulting in enhancement of the signal-to-noise ratio 
between the excited mitral cells and their neighboring unexcited mitral cells (Nakanishi 
et al., 1994). 
Transcripts ofmGluR2 were specifically localized to neuronal cells of the brain. 
Although the hybridization signals were widely distributed in the brain, the most 
prominent expression of mGluR2 messenger RNA was seen in Golgi cells of the 
cerebellum. Marked expression of mGluR2 messenger RNA was further observed in 
the mitral cells of the accessory olfactory bulb (Ohishi et al., 1993). 
Expression ofmGluR2 mRNA and mGluR2-like immunoreactivity (mGluR2-
LI) has been observed in projection neurons of AOB (mitral cells of AOB) but not in 
projection neurons in MOB (Ohishi et al., 1998). In AOB, significant expression of 
mGluR2 mRNA was observed in mitral and granule cells (Ohishi et al., 1993)，and 
mGluR2-LI was found in granule cell dendrites presynaptically at dendrodendritic 
synapses between mitral and granule cells (Hayashi et al., 1993). 
1.7.4. Insulin-like growth factor binding protein-2 (IGFBP-2) 
Insulin-like growth factors (IGFs) play a central role in brain growth and 
development, with IGF-1, its receptors and binding proteins (IGFBPs) being highly 
expressed, particularly in the OB, representing a local paracrine system. A potential 
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role of IGFBPs in transporting and targeting IGFs to their receptors is supported by 
the finding that abundant IGFBP-2 is associated with cell surface proteoglycans 
(Werther et al., 1998). 
IGFS are potent growth-promoting peptides structurally and functionally 
related to insulin. IGF-1 is the major growth factor, while IGF-2 is generally less 
potent. Both IGF-1 and IGF-2 exert their mitogenic effects via the membrane-bound 
tyrosine kinase IGF-1 receptor (Jones and Clemmons, 1995). IGF-1 has been shown 
to significantly promote survival of cerebellar neurons: IGF-1 inhibits apoptosis 
induced by low intracellular potassium (D'Mello et al., 1993). IGF-1 also enhances 
oligodendrocyte survival by inhibiting apoptosis by regulating signaling pathways, 
protease cascades, and mitochondrial integrity (Leventhal et al., 1999). 
IGFS, when isolated from serum or tissue fluids, are usually found as part of a 
protein complex which also contains one or more IGFBPs. Seven IGFBPs (IGFBPs 1-
7) have been identified, cloned and sequenced. They are widely synthesized, with 
distinct expression patterns in each tissue. Circulating IGFs are almost entirely bound 
to IGFBPs in a ternary complex, while paracrine IGFs are variously bound to the 
predominantly locally synthesized IGFBP. The IGFBPs may thus play a 'buffering' role 
for free IGFs, or alternatively, some of the IGFBPs may be involved in tissue targeting 
of IGFs to their receptors (Bach et al., 1995). 
One member of the IGFBP family, IGFBP-2 has previously been shown to be 
produced during early fetal development (Streck and Pintar’ 1992). It is found that 
IGFBPS are expressed in the newborn rat OB, with increasing expression of IGFBP-2 
in glial cells of the glomerular cell layer (Russo et al., 1994). 
IGF-1 is known to complex with IGFBP-2 and it potentially acts as a 
presentation molecule for IGF-1 as it also binds to heparin side-chains on cell-surface 
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proteoglycans (Russo et al., 1997) thus, IGFBPs may either facilitate or inhibit IGF-1 
activity depending on their concentration (Arai et al., 1996; Brooker et al., 2000). 
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2. Materials and methods 
2.1. Animal study 
At day 20 of their pregnancy, mother Sprague-Dawley rats were injected 
either with testosterone propionate (TP) at the dose of 2 mg/1 ml per day or equal 
volume of corn oil for 3/ 4 days until delivery. Female rats from the TP-treated mother 
rats were further treated with TP at the dose of 0.1 mg/0.05 ml for day 1 and 3； 0.2 
mg/0.1 ml for day 5 and 7 and 0.3 mg/0.15 ml for day 9, Both female and male baby 
rats from the corn oil treated mother were treated with equal volume of corn oil. SD 
rats of 2, 5，10，15, 20, 25, 30 and 45 days old were used in this study. Groups of 
male (M), female (F) and neonatal TP-treated female (TPF) rats at the size of six each 
were killed by rapid decapitation and their brains were dissected on petri-dish lying on 
wet ice. The olfactory bulbs were collected and then frozen immediately in liquid 
nitrogen and stored at -70°C until preparation of total RNA. 
2.2 RNA extraction 
In this study, the frozen tissue was weighted and homogenized using a 2 ml 
all glass homogenizer and the total RNA from the tissue is prepared using the RNeasy 
Mini Kit supplied by Qiagen (Qiagen GmbH, Hilden, Germany). The procedures were 
summarized in the following picture (Fig. 2.1). 
The yields of RNA from brain tissue extraction are relatively lower than those 
from the other tissues. To guarantee a better yield, a larger volume of lysis buffer was 
used in this study, i.e. 600 of Buffer RLT was need for 30 mg of tissue. An 
important point is that (3-Mercaptoethanol (p-MR) must be added to Buffer RLT 
before use (10 P-ME per 1 ml of Buffer RLT). 
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Fig. 2.1. Flow chart shows RNA extraction procedure by RNeasy Mini Kit (Qiagen, 
Germany). 
After disruption and homogenization, the lysate was centrifuged for 3 minutes 
at maximum speed in a microcentrifuge. The supernatant was then collected. One 
volume of 70% ethanol was added to the supernatant to the cleared lysate. The 
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mixture was mixed well by pipetting. Precipitate formed after the addition of ethanol 
would not affect the RNeasy procedure and centrifugation was avoided during this 
step. Ethanol was added to provide an appropriate binding condition which is essential 
in later steps. Including any precipitate which may have formed, 700 |al of the sample 
was applied to an RNeasy mini spin column, where the total RNAs bind to the 
membrane and contaminants are efficiently washed away. The column was sited in a 2 
ml collection tube and was centrifuged for 15 seconds at 10,000 rpm. If the volume of 
the mixture exceeds 700 ^1, the remains were loaded successively onto the RNeasy 
column and centrifuged as in the last step. Then, the RNA was washed with 700 [i\ of 
Buffer RW1 by centrifuging for 15 seconds at 10,000 rpm to wash the RNA. After 
that, both of the flow-through and collection tube were discarded. RNeasy column was 
transferred to a new 2 ml collection tube. 500\x\ of working RPE Buffer was added 
onto the RNeasy column and centrifuged for 15 seconds at 10,000 rpm to wash the 
RNA. As Buffer RPE was supplied as a concentrate, 4 volumes of absolute ethanol 
should be added to obtain a working solution before using for the first time. Five 
hundred microliters of Buffer RPE was again added onto RNeasy column and 
centrifuged for 2 minutes at maximum speed to dry the RNeasy membrane. It was 
important to dry the RNeasy membrane since residual ethanol might interfere with 
subsequent reactions. This spin ensured that no ethanol was carried over during 
elution. Following the spin, the RNeasy column was removed from the collection tube 
carefully to make sure that the column did not contact the flow-through as this would 
result in carryover of ethanol. RNeasy column was then transferred into a new 1.5 ml 
collection tube. Fifty-five mircoliters of RNase-free water was pipetted directly onto 
the RNeasy membrane. Five minutes later, it was centrifuged for a minute at 10,000 
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rpm. Fifty-five microliters of RNase-free water was pipetted again onto the membrane 
and was centrifuged for 1 minute at 10,000 rpm after sitting for 5 minutes. 
The method of precipitation was used to concentrate the total RNA. A 
hundred microliters of filtrate and 0.1 volume of 3M sodium acetate (10 ^1) were 
added onto a new 1.5 ml collection tube. Then, 2.5 volume of ice-cold absolute 
ethanol (275 \il) was added into the tube. The solution of mixture was stored at -70°C 
for 3 hours and then was centrifuged for 20 minutes at 10，000g in 4�C. The 
supernatant was discarded and 100 of ice-cold 70% ethanol was added. It was then 
centrifuged for another 20 minutes at 10，000g in 4 � C to remove the excess sodium salt. 
The RNA pellet was retained and dried in Speed Vacuum for 5 minutes. It was then 
dissolved in 10 (il ofRNase-free water and stored at -70�C, 
2.3. Quantitation of total RNA 
The concentration and purity of RNA can be determined by measuring the 
absorbance at 260 nm (A260) and 280 nm (A280) in a spectrophotometer. An 
absorbance of 1 unit at 260 nm corresponds to 40 jig of RNA per ml (A260 二 1 = 40 
g/ml). This relationship is valid for measurements in water. The ratio between the 
absorbance values at 260 and 280 nm gives an estimate of RNA purity. Pure RNA has 
an A26o/A28o ratio of 1.5 - 1.9 in water. An example of the calculations involved in 
RNA quantitation is shown below: 
Volume of RNA sample = 10 
Dilution = l\x\ of RNA sample + 99 \x\ dH20 (1/100 dilution) 
Measure absorbance of diluted sample in a 50 \x\ curette 
A26O 二 0.75 
49 
When measured in water an A260 value of 1 is equal to 40jig/ml ofRNA; 
therefore, concentration of original RNA sample = 40 x A260 x dilution factor 
=40 x 0.75 x 100 
=3000 jig/ml 
Total yield = concentration x volume of sample (ml) 
=3000 jag/ml x 0.01 ml 
= 30|ig 
2.4. Reverse Transcription (RT) 
Following the extraction of total RNA from the tissue, the complementary 
DNA (cDNA) was synthesized by reverse transcription. Reverse transcriptions of the 
samples are performed using polydT12-i8 (Pharmacia Biotech, USA) as primer which 
annealed to the poly A tail of the mRNA. In this study, 6 jig of total RNA prepared 
was added into a 600 |il thin-wall eppendorf. One microliter of 50 |iM polydT12.18 was 
added. The volume was make up to 12 i^l by DEPC-treated H20. It was incubated at 
70°C for 10 minutes and was quick chilled in ice for 2 minutes. Then, 4 \i\ of 5X First 
Strand Buffer (Gibco BRL, USA), 2 ofO.lM DTT (Gibco BRL, USA), 1 |il of 10 
mM dNTPs (Gibco BRL, USA) and 1 \x\ of SuperScript II RNase H" reverse 
transcriptase (Gibco BRL, USA) were added and mixed well. It was then incubated at 
37°C for 1 hour and followed by an inactivation process at 90°C for 5 minutes, using 
PTC 100 theromocycler (MJ Research, USA). After all, the RT products are cooled at 
4°C, aliquoted into smaller portions and stored at -20°C until PCR processes. 
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2.5. Polymerase Chain Reaction (PCR) 
The RT products prepared were diluted to 20 ng/[i\ as a working 
concentration for PCR. They are aliquoted and stored at -20°C until PCR processes. 
Equal amount of cDNA of all samples are pooled to form a large sample pool for 
standard curve construction. 
The conditions for PCR were optimized by titrating the Mg2+ ion 
concentration, annealing temperatures, initial amount of RT products and the cycle 
numbers for each primer set in pooled samples (Fig.2.2). The primers, size, annealing 
temperature, cycle number and Mg2+ concentration used in present study are 
summarized in Table 2.1. 
To design a specific primer set for PCR amplification, the sequence of the 
primer should be unique within the region to be amplified. Self-homology of the 
primer should be avoided to prevent hairpin formation, G/C ratio about should be 45 
to 55% and the primer length should be around 18 to 25 bases. 
The PCR reaction mixture contained 2 of 10X PCR buffer IV, variable 
amount of 25 mMMgCl2, 1 |il of each of sense and antisense primers (15 2 of 
cDNA template (20ng/ \x\), OA }il of dNTPs (10 mM) and finally 0.2 \x\ of 2.5 units 
native Taq DNA polymerase. The mixture was made up to a volume of 20 |il with 
autoclaved distilled water. The mixture was mixed will in a 600 thin-wall tube and 
was heated in a PTC 100 theromocycler (MJ Research, USA) at 94�C for 2 minutes to 
denature the template completely. Then the PCR was performed for optimal cycles: 
94°C for 1 minute; annealing temperature for 1 minute and 72°C for 2 minutes. This 
was followed by 10 minutes incubation at 72�C to complete the PCR. And the PCR 
products were kept at 4°C. 
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A. 
• • P S 
B. 
Fig 2 2 (A) Picture shows the bands of individual gene amplified under optimal or sub-optimal 
conditions Smearing o fDNA can be observed in lane with the PCR product amplified under sub-
optimal condition. (B) Picture shows the titration of cycle number. Intensities of bands increase with 
the cycle number. Saturation occurred when PCR was performed with excess cycle number. 
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Specific primer sets for PCR 
N a m e Sequences No. of Annealing No of Cone of 
麵 ： ； y ) base pairs temperature cycle MgCh 
p.actin S: TCA TGA AGT GTG ACG TTG AC 285 b.p. 60°C 19 1 0 
AS: CCT AGA AGC ATT TGC GGT GC 
AR S: CCC AGG AAT TCC TGT GCA TGA AAG C 458 b.p. 60 °C 29 1.0 
AS: CCC CAA GGC ACT GCA GAG AAG TAG T 
ERp s： TTC CCG GCA GCA GCA CCA GTA ACC 262 b.p. 64 °C 37 1.0 
AS: TCC CTC TTT GCG TTT GGA CTA 
Aromatase S: GGA GGA TGA CGT GAT TGA CG 334 b.p. 60 °C 33 1.0 
AS: TTC CAC AAT GGG GCT GTC 
OSCP S: CAG GTC TAC GGC ATC GAA GG 312 b.p. 65 °C 21 1.5 
AS: ACG GTG GAC ACT CAT GAT GG 
B c l . 2 a S: ACA GCC AGG AGA AAT CAA A 330 b.p. 60 °C 29 1.0 
AS: GTC GCT ACC GTC GTG ACT T 
Caspase3 S: GGT ATT GAG ACA GAC AGT GG 268 b.p. 60 °C 23 1.5 
AS: CAT GGG ATC TGT TTC TTT GC 
SemalE S: ACC ATC ATC CCA TCA GGA CC 341 b.p. 6 3 � C 24 1.0 
AS: ATT GGG ACC TGG CAC AGA GC 
Neuropilin-1 S: GAA GIT TAT GGC TGC AAG 633 b.p 57 °C 25 1.0 
AS: CTT CTC TGT GGC CAG GAC 
Plexin-1 S: CAC CTG GAC CAA CGT GAA GGC 214 b.p. 69 °C 28 1.5 
AS: CGT GGA TCT GAT GCT TGT CGG 
CRMP-1 S: GAT GGA CTC ATA AAG CAA ATA 259 b.p. 60 °C 24 1.0 
AS: CGT GCC ATT TCT CAA AGG AAG 
CRMP-2 S: GAT GGG TTG ATC AAG CAA ATA 261 b.p. 60 °C 25 1.0 
AS: CTC CCT CCA CTG ATC AAA GGC 
CRMP-3 S: GGA GGA CGG TCT GAT TAA AC 524 b.p 66 °C 28 1.0 
AS: GCG CTT CTG TTC CTC CTC CA 
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Name Sequences No. of Annealing No. of Cone, of 
(51 to 3') base pairs temperature cycle MgCh 
CRMP-4 S: ATG TCC TAC CAG GGC AAG AAG 447 b.p. 66 °C 27 1.0 
AS: CTT GAC GOT GTC ATT CCA GTG 
GAP43 S: ACA AGG AAA AAG CTC AAA G 292 b.p. 55 °C 24 1.0 
AS: GAC GGG GAG TTA TCA GTG G 
OMP S: GCT GTA GCA CTT GGG CCA TG 490 b.p. 61 °C 27 1.0 
AS: ATC AGA GCT GGT TAA ACA CC 
G o l f S: TCG GAG TGC GAG CCA GCA 400 b.p. 61 °C 28 2.0 
AS: GAT AGG GGC TAT GCT CTT 
S P S: ATG AAA ATC CTC GTG GCG GT 219 b.p. 60 °C 27 1.0 
AS: CAG CAT CCC GTT TGC CCA TT 
GnRH S: GCA CTA TGG TCA CCA GCG GG 477 b.p. 69 °C 33 2.0 
AS: CAT GGA TCT CAG CGT CAA TG 
mGluR2 S: TTT AGG TCA GAA GCC AGA GT 250 b.p. 61 °C 25 1.0 
AS: CAG TAA CCA TCC TCT CTA TCC 
！GFBP-2 S: GCA GGT TGC AGA CAG TGA GG 293 b.p. 62 °C 25 1.0 
AS: GAA GGC GCA TGG TGG AGA TG : * 
Table 2 1 A summary of sense (S) and anti-sense (AS) primers sequences, amplicon size, 
annealing temperature, cycle number and Mg2+ concentration used in this study. 
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PCR products were separated by electrophoresis in 2% agarose gel 
(electrophoresis grade, Bio-Rad, USA) containing 0.5 mg/ml ethidium bromide in IX 
TAE buffer (40 mM Tris, 20 mM sodium acetate, 1 mM EDTA, pH 7.2) and visualized 
under 310nm ultra violet (UV) light. The band of the correct size, as determined by 
comparison with 100 b.p. DNA marker (Gibco BRL, USA) was cut from the gel and 
purified by a USBioclean MP Kit (United States Biochemical, Cleveland, USA). 
2.6. Purification of PCR products 
The specific DNA band was excised from the ethidium bromide-stained agarose 
gel using a razor blade under minimal 310nmUV exposure to avoid nicking of DNA. The 
agarose was then weighted and put into a 1.5ml tube with 3 volumes (1 ml/g of gel) of 
sodium iodide (Nal) solution added. It was then incubated at 55°C for 5 minutes to 
dissolve the agarose. Five microliters of glass powder suspension from USBioclean MP 
Kit (United States Biochemical, Cleveland, USA) was added. The glass powder 
suspension contains a specially formulated silica matrix that binds single and double 
stranded DNA but not the other contaminants. After vortexing to mix the content, the 
tube was placed in ice for 5 minutes to allow the binding of DNA to the silica matrix. It 
was then centrifuged at 3000 rpm for 10 seconds to separate the glass powder. The 
supernatant was then discarded and the pellet was washed 3 times, each with 500 of 
prepared 50% ethanol rinse buffer. The rinse buffer was removed as much as possible 
using a fine pipet tube after final centrifligation. Then the pellet was resuspended in 10 
of DEPC-treated H 20 and incubated at 55°C for 5 minutes. After incubation, it was spun 
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down for 1 minute at 3000 rpm and the supernatant containing the eluted DNA was 
collected. The DNA was eluted once again and the supernatant was collected. The 
supernatant was then confirmed by DNA sequencing. The procedure is simplified as Fig. 
2.3. 
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Fig. 2.3. Flow chart shows the gene clean procedure by USBioclean MP Kit (United 
States Biochemical, Cleveland, USA) 
2.7. Confirmation of PCR Products 
To perform sequencing, the following mixture contained 30-90 ng PCR product 
as template, 3.2 pmole of upstream primer, 8 of deRhodamine Terminator Ready 
Reaction Mix (PE Bio Systems, California, USA) and DEPC-treated H20 to 2(^1. It was 
heated to 96°C for 3 minutes, then the amplification was performed in a PTC 100 
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theromocycler (MJ Research, USA) for 25 cycles under the cycling conditions: 96�C for 1 
minute followed by 50�C for 1 minute and 60�C for 4 minutes. Then the reaction product 
was loaded into a Mirco Bio-Gel P-30 (Bio-Rad, California, USA) column and 
centrifuged at 5,000g for 4 minutes to remove free nucleotides and primers. The fraction 
collected was mixed well with an equal volume of Template Suppression Reagent (PE 
Applied Biosystems, USA) and incubated at 95°C for 2 minutes. Finally，the tube was 
quickly chilled in ice, and the content was analyzed using an automated DNA sequencer 
(Advanced ABI310 Genetic Analyzer, Perkin-Elmer, CA, USA). The sequencing data 
obtained were submitted to the BLAST Sequence Similarity Search (NCBI, National 
Centre for Biotechnology Information; http//:www.ncbi.nlm.nih.gov.BLAST). In all 
cases, the authenticity of sequences of genes in present study was confirmed. 
2.8. Quantitation of cDNA 
The amount of cDNA template generated was measured by incorporation of 
labeled dCTP. Usually, normalization with housekeeping gene is used to correct the error 
arising from the incomplete transcription from total RNA to cDNA and insensitivity of the 
absorbance measurement. In previous study, it was found that when target genes were 
normalized with different housekeeping genes, discrepancy on significant effects of age, 
sex and their interactions were found (Wong et al., 2000). Besides, in this study, the 
housing-keeping gene-p-actin, was found to be affected by the age and treatments. 
Therefore, the recently developed fluorescence probe OliGreen (Molecular Probes, USA) 
for the measurement of single strand DNA (ssDNA) were used to measure the 
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concentration ofcDNA in each sample. The 20X TE buffer (pH 7.5) included in the kit 
was diluted 10-fold with autoclaved nanopure H 2 0 for diluting the OliGreen reagent and 
cDNA samples. 
To prepare the samples, 5 \x\ of sample cDNA (20 \xg/[i\) was added to the well 
of the FluoroNunc Plate (Nunc, Denmark). It was then made up to 100 jil with IX TE 
buffer. A five-point standard curve (25ng, 50ng, lOOng，200ng and 300ng per well) 
(Fig.3.2) was prepared with the cDNA pool. Finally, the OliGreen reagent was diluted 
200 folds with IX TE buffer to a working concentration. As the OliGreen reagent is light 
sensitive, it was prepared in dark and covered with aluminum foil. Two minutes before 
the measurement, 100 |al of OliGreen reagent was added into each well of the plate 
automatically in the 1420 Victor2 Multilabel Counter (Wallac，Finland) using wave lengths 
480 nm for excitation and 520 nm for emission. The mixtures were mixed well and stood 
for 2 minutes to ensure the reaction complete before the measurements. The relative 
concentration of cDNA amount of individual sample was obtained by reading from the 
standard curve. 
2.9. Radioactive labeled PCR 
Radioactive PCRs were performed. Before amplifying the samples, the optimal 
cycle number should be pre-titrated by cycle titration to avoid plateau effect too early 
observed in the standard curve (refer to Fig. 3.1 in Results) and thus the samples are 
amplified within the linear range. The radioactive PCRs were performed in 0.6 ml thin-
w a l l t ubes with 2 10X PCR buffer IV，1 |il of each of the primers (sense and antisense) 
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(15|iM), optimal amount of 25 mM MgCl2, 2 jal ofcDNA template (20 ng/^1), 0.4 卩 1 of 
dNTPs (10 mM), and 0.2 \i\ of 2.5 units native Taq DNA polymerase. The total volume 
was made up to 18 jil with autoclaved distilled H20. Finally, 2 of32P dCTP (1 ^Ci/2 pi) 
was added to the mixture. The mixture was mixed well and spun down and the PCR was 
carried in a PTC 100 theromocycler (MJ Research, USA) for optimal cycles. The cycling 
conditions were 94�C for 2 minutes followed by cycles of 94�C for 1 minute; annealing 
temperature for 1 minute and 72°C for 2 minutes. This was followed by 10 minutes final 
extension at 72°C. The reaction was terminated by reducing the temperature to 4°C. The 
products were kept at 4�C in perspex box with lcm thick wall until separation with PAGE 
(Polyacrylamide gel electrophoresis). 
2.10. Electrophoresis of PCR products 
The PCR products were separated by 8% native PAGE. Thirty percent 29:1 w/w 
acrylamide solution was prepared by dissolving 150g acrylamide (Gibco BRL, USA) and 
5.17g N^-methy leneb i sac ry lamide (Amersham Life Science, UK) in distilled H 2 0 to a 
volume of 500 ml. The solution was stirred until the all the crystal was dissolved. Then it 
was filtered through 0.45 ^m HAWP filter paper (Milipore, USA). 
The 5X TBE buffer was prepared by dissolving 54g Tris Base (Roche 
Diagnostics, Germany), 27.5g of boric acid (Amersham Life Science UK), 20 ml of 0.5M 
EDTA pH 8.0 with distilled H20 which the total volume was made up to 1L. The solution 
was mixed well and filtered through 0.45 i^m HV filter (Millipore, USA). 
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In this study, the 8% polyacrylamide gel was prepared by mixing the 44 ml 30% 
acrylamide solution, 33 ml 5X TBE buffer and 88 ml distilled H20. And 1820 [i\ 10% 
ammonium persulfate (Bio-Rad, USA) and 193.4 TEMED (N,N,N',N'-
tetramethylethylenediamine) (Roche Diagnostics, Germany) were added and mixed well 
to polymerize the gel. The solution was poured into the space between two pieces of glass 
and allowed to set. 
Before loading the samples into the well of the gel, the samples were mixed with 
2 jal of gel-loading dye (50% Glycerol, IX TAE buffer，2% bromophenol blue, 1% xylene 
cyanol). After electrophoresis, the gel was transferred to a 3MM chromatography paper 
and exposed to the Bl-screen of a Phosphorimager (Bio-Rad, CA, USA) without drying in 
sealed thin plastic bags. The relative radioactivities were scanned with the Molecular 
Imager GS-525 and analyzed using the software package Molecular Analyst (Bio-Rad, 
C ^ USA). The data obtained was then corrected with the calculated concentration of 
cDNA. 
2.11. Statistical analysis 
Data were subjected to analysis by two-way ANOVA using the statistical package, 
SPSS-PC+. By two-way ANOVA, the effects of age, treatments and their interaction (age 
x treatments) during the OB development are compared at the same time in female, male 
as well as TP-treated female rats. Statistical results are summarized in tables including the 




3.1. Standard curve construction 
In this study, the expression of different genes in the OB of neonatal treated 
(F), (M) and (TPF) rats are examined at the ages of 2, 5, 10，15, 20, 25, 30 & 45 days. 
Results are shown in histograms on the developmental profiles of various genes 
in the described groups of rats. Tables are used to summarize statistical results of gene 
transcription in three or five groups which represent the: (1) whole development stages 
examined (age groups 1-8); (2) early development stage (age groups 1-3)，i.e. 2，5 & 
10 days and (3) late development stage (age groups 4-8)，i.e. 15, 20，15, 20，25, 30 & 
45 days; (4) pre-pubertal stage (age groups 1-5), i.e. 2, 5，10，15，20 days and (5) 
pubertal and post-pubertal stage (age groups 6-8)，i.e. 25, 30 and 45 days of age. 
Calibration curve for synthesized cDNA 
200000 t：；：；：；：；：；：；：；：；：：；：；：：；：：：^ 
150000 
c • RT pool 
I 100000 Regression 
50000 
o 50 100 150 200 250 
Amount of total RNA (ng) 
Fig. 3.1 Results of standard curve constructed with the RT-product pool. 
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Oligonucleotides of 18，20 and 30-mer used for construction of the standard 
curves were found to be not suitable for the quantitation of RT-products (Wong et al. 
unpublished data). In this study, a pool from the individual RT-products was used to 
construct the standard curve for the determination of cDNA amounts in the RT-
products (Fig. 3.1). 
3.2. P-actin 
In this study, statistical analysis (Table 3.1 & 3.2) on the developmental profile 
(Fig. 3.3 & 3.4) of p-actin without or with correction with cDNA amount indicated 
significant age, treatment and their interaction effects. Comparing the data without 
and with correction of cDNA amount, the following points should be noticed: (1) the 
treatment effect in p-actin gene expression is more evidenced when the data is 
corrected with cDNA (p<0.001 vs p < 0 . 0 2 ) ; � significant sex difference and treatment 
effects (M/TPF) at the level ofp<0.02 & p<0.001 respectively are found with cDNA 
correction and (3) similarly, in groups 4-8 i.e. during the late development, with cDNA 
correction, the sex difference (F/M) and treatment effect of male to TP-treated female 
(M/TPF) become significant at the level of p<0.05 & p<0.01 respectively. The present 
results indicate that data from p-actin cannot be used to correct the unequal amount of 
templates added into individual PCR tubes. Therefore, the cDNA amounts of 
individual sample are used to correct the unequal amount of cDNA template added 
into each PCR tube. The fluorescence dye for single strand DNA (ssDNA)-01iGreen 
(Molecular Probes, OR., USA) was used for quantitative determination of cDNA 
• 2 
concentrations in this study. The fluorescence was measured with the 1420 Victor 
multilabel counter (Wallace, Finland) and concentrations of the RT-products were read 
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Fig 3 2 Images of the standard points of PCR products of (A) P-actin gene and (B) 
androgen receptor (AR) gene captured by the BI screen of the Molecular Imager 
GS525 and their standard curves for the estimation of transcriptions of all the 
unknown samples. X-axis indicates a serial dilution of cDNA sample pool from this 
study, which contains cDNA reverse transcripted from 10 to 160ng total RNA. 
Using pooled RT-products for the construction of standard curves for target 
gene PCRs, representative standard curves and images of standard points of p-actin 
and AR genes are illustrated in Fig. 3.2. Representative images of CRMP-4 gene are 
shown in Fig. 3.2a. 
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PCR products of female rats at Standard curve 
different ages 
Fig. 3.2a. Images of the representative samples from day 2 to day 45 of female rats and 
their standard points of PCR products ofCRMP-4 gene captured by the BI screen of 
the Molecular Imager GS525. 
3.3. Sexual differentiation related genes 
To study the sexual differentiation related gene expression during the 
development in rat olfactory bulb, expressions of AR, ERp，aromatase and OSCP 
. g e n e s are examined. 
3.3.1. AR 
Statistical results summarized in Table 3.3 indicate significant overall age and 
interaction effects (age x treatment) on the transcription of AR gene. This age effect is 
not observed among 1 to 3 and 6 to 8 age groups but strongly evidenced among the 1 
to 5 and 4 to 8 age groups. From Fig. 3.5，significant interaction effects are obviously 
coming from the differential response of AR gene transcription to the treatments at the 
age of 25, 30 and 45 days. A weak but significant sex difference (p<0.05) is found 
among groups at all the ages. A similar treatment effect between the male and the TP-
treated female (M/TPF) is observed in the 1 to 5 age groups (p<0.05). 
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3.3.2. ERp 
The developmental profile ofERp gene (Fig. 3.6) is not so obvious as in the 
AR gene (Fig.3.5). However, its transcription drops at day 20. As indicated in Table 
3.4，the ERp gene expression is significantly affected by age (p<0.001) and interaction 
(p<0.05), but not the treatments. It is also found that the age difference in its 
expression is mainly observed from group 1-5 or 4-8 (both at the level of p<0.001). 
This is apparently the consequence of having a significant decrease in expression at day 
20 (Fig. 3.6) 
3.3.3. Aromatase 
As in the expression ofERp gene, aromatase gene shows no distinct pattern in 
its developmental profile (Fig. 3.7). As indicated in Table 3.5，the aromatase gene 
expression is significantly affected by age (p<0.01), treatment (p<0.02) as well as their 
interaction (p<0.02). This age differences are mainly observed from the pre-pubertal 
stages (Days 2, 5, 10, 15, & 20) at the level of p<0.005 and the treatment effect is 
found to be due to differences between both F/TPF (p<0.01) as well as M/TPF rats 
(p<0.05). The peak of aromatase gene transcription is at around day 10. It is followed 
by a drop at day 20 and return to get to the adult's level afterwards (Fig. 3.7), Injection 
of TP，the substrate for aromatase, induced the transcription of this gene at day 2, day 
5 as well as day 30. Again, significant age effects are observed not only among the age 
groups 1-5 (p<0.005) but also among the 4-8 age groups of rats (p<0.05). Age groups 
1-3 and 6-8 do not seem to show any significant difference in expression ofERp gene. 
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3.3.4. OSCP 
As shown in Fig. 3.8，the expression of OSCP gene reaches a peak at day 5 and 
day 25. Particularly low level of OSCP gene transcription is found at day 20. Results 
of Table 3.6 indicate that OSCP gene expression is significantly affected by age 
(p<0,001)，treatment (p<0.05) and their interaction (p<0.001). Significant treatment 
effect is probably due to the significant higher level of OSCP gene transcription in the 
male OB at day 2 & 5. Significant differences between F/M and M/TPF rats in OSCP 
gene transcription (Table 3.6) are also observed among age groups 1 to 3 (p<0.02 & 
p<0.02) and groups 1 to 5 (p<0.05 & p<0.005). 
3.4. PCD related genes 
To study the expression of PCD related gene in rat OB during the 
development, bcl-2a and caspase 3 gene expressions are examined. 
3.4.1. Bcl-2a 
As illustrated in Fig. 3.9, bcl-2a gene expression is found to reach its peak at 
day 5 and decreases gradually to day 20. This is followed by an increase in its 
expression again to day 45. As shown in Table 3.7，the expression ofbcl-2a gene in 
the rat OB is significantly affected by age (p<0.001)，treatment (p<0.02) and their 
interaction (p<0.001). No sex difference as well as interaction between age and sex is 
evidenced among the female and male (F/M) rats (Table 3.7). The significant 
treatment effect is mainly due to the effect of TP treatment at the early postnatal, i.e. 
age groups 1 to 3 (F/TPF p<0.02; M/TPF p<0.005) and the prepubertal period, i.e. 
age groups 1 to 5 (both F/TPF and M/TPF at the level of p<0.005) (see results in 
Table 3.7). 
66 
3.4.2. Caspase 3 
In case of the transcription of caspase 3 gene, a higher level of mRNA is found 
in the early postnatal development, i.e. age groups 1-3 of the rat OB (Fig 3.10). It is 
also found that the expression of caspase 3 gene is significantly affected by age 
(p<0.001) and interaction (p<0.001) but not by treatments (Table. 3.8). Age 
differences of this gene expression are due to the apparent drop of its transcription at 
day 20. Among early phase of its development, no significant age effect is observed 
(Fig. 3.10 & Table 3.8). 
3.5. Axon guidance molecules and related genes 
In order to study the role of the axon guidance molecules during the 
development of rat OB，expressions of axon guidance molecules and their receptors as 
well as the collapsin response mediator protein genes are examined. They are the sema 
III gene, the putative semaphorin receptor protein genes neuropilin-1 and plexin-1 as 
well as CRMP-1, 2, 3 and 4 genes. 
3.5.1. Sema III 
Sema III is a member of semaphorins gene family. Semaphorins are axon 
guidance molecules that work mainly as repellent providing inhibitory signals to 
growth cones of neurons. As shown in Fig. 3.11，its expression remains high at day 2 
and day 5 and then decreases gradually to day 30 and increases again at day 45. 
Results of statistics (Table 3.9) indicate that sema III gene expression is significantly 
affected by age (p<0.001) and interaction (p<0.005). Treatments are not affecting the 
transcription of sema III gene while the significant effect indicating under some stages 
of the development, distinct treatment effect is observed e.g. at day 2 and day 20. 
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Among the 1 to 5 age groups, significant treatment effect at the level of p<0.05 is 
observed between the F/TPF rats. Interestingly, the differences of the interaction are 
mainly due to the 1-3 and 1-5 age groups and between the treated rats and control rats 
(F/TPF p<0.001; M/TPF p<0.01) but not the control males and females (F/M). 
3.5.2. Neuropilin-1 
As shown in Fig. 3.12, neuropilin-1, the receptor gene of sema III was found to 
be transcripted most highly at day 2 and day 5. It decreases sharply at day 10 and 
remained at a low transcription level to the nearly undetectable level at day 45. 
However, there is a slightly increase in its expression at day 25. Results of statistical 
analysis (Table 3.10) show that the expression of neuropilin-1 gene is significantly 
altered by the age (p<0.001) and the interaction (p<0.001) but not by the TP-
treatment. And the effect of the interaction is found to be due to the differences in 
expression between the F/TPF and M/TPF (both at the level of p<0.001) but not 
between the F/M in the early development and pre-pubertal stages (i.e. 1-3 & 1-5 age 
groups). Significant treatment effect is, however indicated between F/TPF rats at the 
late development stages (among 4-8 p<0.05 & 6-8 p<0.005 age groups). The 
significant interaction effects are probably due to the stimulatory effect of TP-
treatment at day 2, 10，25 and 30 but suppressive at day 5 age groups between the 
F/TPF rats. 
3.5.3. Plexin-1 
In case of the plexin-1 gene, variations of its expression among most age 
groups are high. As summarized in Table 3.11, results of statistics show that plexin-1 
gene is significantly affected by age (p<0.001), but the difference is mainly due to the 
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changes in expression during the late development stages (4-8 or 6-8 at the level of 
p<0.001 and p<0.05 respectively). There is no significant effect of treatment and 
interaction in its gene expression. Significant effects of age and treatment (both at 
p<0.001) and interaction (p<0.05) in its gene expression are found in the late 
development stages (group 4-8). However, there is no significant change in gene 
expression during the early development (both groups 1-3 and 1-5) and so the net 
effect is canceled out. Significant differences between M/TPF rats at day 20 (see Fig. 
3.13 and refer to M/TPF of group 4-8 in Table. 3.11) are probably the consequence for 
the significant treatment effect at the 4-8 age group. 
3.5.4. CRMP-1 
CRMP-1 to 4 are the mediator proteins of semaphorins. First of all, CRMP-1 
is expressed apparently higher at day 2 and day 5. Its transcription decreases sharply 
after day 5 and remains at a low transcription level in other stages of development (Fig. 
3.14). Statistical analysis (Table 3.12) shows that the CRMP-1 gene expression is 
significantly affected by the age，treatment and their interaction (all at the level of 
p<0.001). The treatment effects are mainly on the early development stages (among 
g r 0 Up i to 3 (p<0.02) and 1 to 5 (p<0.005) age groups, see Table. 3.12). Sex 
differences of CRMP-1 gene expressions are also indicated in the early development 
(group 1-3) of the OB (p<0.02). Treatment effects are observed, however, in the late 
development i.e. group 4-8 and 6-8 for the F/TPF rats (both at the level of p<0.05) and 
M/TPF in the early development i.e. group 1-3 and 1-5 (both at the level of p<0.01) 
(see Table 3.12). 
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3.5.5. CRMP-2 
For CRMP-2 gene, its expression decreases gradually from day 2 to day 15, 
with a slightly increase at day 20 and day 45 (Fig. 3.15). From Table 3.13，it is 
indicated that the CRMP-2 gene expression during the development is significantly age 
dependent (p<0.001) and the differences are related to the changes of transcription 
level in both early and late development stages (both in the level of p<0.001). No 
significant sex difference is found. Concerning treatment effects, significant differences 
are found between the F/TPF (p<0.005) and M/TPF (p<0.02) rats at the early stage of 
development (1-3 age groups). TP-treatment significantly reduces the expression of 
CRMP-2 gene at day 2 to day 10 (Fig. 3.15). Besides, there is a significant interaction 
difference (p<0.001) in its expression in rat OB, indicating differential expressions of 
this gene in some age groups for example, TP-treatment suppresses CRMP-2 gene 
transcription at day 2，5, 10, while increases it at day 15 & 20 (Fig. 3.15). 
3.5.6. CRMP-3 
For CRMP-3 gene, it is transcripted most highly in day 2 and day 5, and it 
decreases gradually to day 20. However, its expression increases again at day 25 and 
day 30 and returns to a lower level at day 45 (Fig. 3.16). From Table 3.14, it is found 
that the expression of CRMP-3 gene in rat OB is significantly affected by age, 
treatment as well as their interaction all at the level of p<0.001. Also, from the table, it 
is found that the effects are due to the differences of transcription during both the early 
and late development stages. Sex differences of the CRMP-3 gene transcription are 
indicated at the early developmental stages (among 1-3 (p<0,02) & 1-5 (p<0.05) age 
groups). Treatment effects are observed between F/TPF but not M/TPF rats in all age 
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groups, indicating androgen affects the transcription of this gene in the female rat (1-3， 
4-8 & 6-8 age groups at p<0.005; 1-5 at p<0.01). 
3.5.7. CRMP-4 
CRMP-4 gene, as shown in Fig. 3.17，its expression is particularly high at day 2 
and day 5. It drops sharply at day 10 and remains at a low transcription level 
thereafter. It is relatively similar to the expression pattern of CRMP-1 (see Fig. 3.14). 
Like other members of CRMP genes, CRMP-4 gene transcription is significantly age 
dependent (p<0.001) in rat OB (Table 3.15). Even though no significant sex difference 
(F/M) is found in the expression of CRMP-4 gene, significant treatment effects are 
found between the F/TPF rats at the age groups of 1-3 (p<0.05)，4-8 (p<0.001) and 6-
8 (p<0.05). Differential treatment effects (p<0.001) on its transcriptions are also 
evidenced (Table 3.15). 
3.6. Olfactory marker protein genes 
Besides, expressions of a number of marker protein genes were also examined 
during the development of OB in this study. They are the growth associated protein 
(GAP-43), olfactory marker protein (OMP) as well as olfactory G-protein (G0if) genes. 
3.6.1. GAP-43 
From Fig. 3.18, the transcription of GAP-43 gene is high at the early stages of 
development and it drops at the late development stages. In Table 3.16，it is found 
that the expression of GAP-43 gene is age dependent (p<0.001) and it is affected 
significantly by the interaction (p<0.01) but not the treatments. The weak treatment 
effect (p<0.05) at the late development stages is the results of having significant 
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difference of its transcription between M/TPF rats at the age groups of 4 to 8 
(p<0.02). 
3.6.2. OMP 
Just opposite to the transcription pattern of GAP-43 gene, OMP gene 
expression stays at a low level during the early development, but it increases from day 
25 and remains relatively high at the late development stages (Fig. 3.19). Results of 
statistical analysis (Table 3.17) show that significant age (p<0.001) and treatment 
(p<0.05) effects on the expression of OMP gene. And it is found that the weak 
treatment effect (p<0.05) is due to change in gene transcription during the late 
development stages between the M/TPF rats at p<0.05. No sex difference in 
transcription of OMP gene—is evidenced. 
3.6.3. Golf 
The Golf gene codes for the olfactory G-protein and its transcriptional pattern 
during the development of rat OB fluctuates without a special form (Fig, 3.20). Its 
drops to a relatively low transcription level at day 20. The TP-treatment seems to 
enhance the gene expression of at day 5 and day 30. From Table 3.18，the G0if gene 
expression is found to be significantly affected by age (p<0.001) and interaction 
(p<0.05) indicating weak differential effect of the treatment on this gene's transcription 
which happens between the F/TPF and M/TPF at different age groups (Fig. 3.20). 
However, no treatment effect is evidenced in its expression. 
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3.7. Miscellaneous genes 
Finally, transcriptions of two neurotransmitter genes and two miscellaneous 
genes are also examined in rat OB. In this study, substance P (SP) and gonadotropin-
releasing hormone (GnRH), metabotropic glutamate receptor subtype 2 (mGluR2), as 
well as the binding protein of insulin like growth factors (IGFBP-2) are investigated. 
3.7.1. Substance P 
From Fig. 3.21, the transcription of SP gene remains apparently constant 
during the development. Age is found to be the only factor affecting the transcription 
0 f sp gene (p<0.001). There is no treatment or interaction effect found in any stage 
during the development of rat OB. 
3.7.2. GnRH 
Expression of the GnRH gene is found to be increased from day 2 to the peak, 
at day 5. It decreases then, gradually to day 20 and remains low at the late 
development (Fig. 3.22). Summary of statistical analysis in Table 3.20 shows that the 
GnRH gene expression is significantly affected by age (p<0.001) and interactions 
(p<0.001) but not by the treatments. The interaction effects are related to the changes 
in its expressions between the F/TPF (p<0.02) and M/TPF (p<0.001) rats during the 
early development (age groups 1-3). Significant treatment effect is found at the late 
stage of the development (age groups 4-8) of TP-treated female rats (p<0.01). At day 
20 and 30, there is an enhancing effect of the TP-treatments on GnRH gene 
transcription in TPF rats. 
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3.7.3. mGIuR2 
In case of mGluR2, its expression is relatively high during the early 
development and becomes lower at the late development stages (Fig. 3.23). Besides, 
the TP-treatment seems to affect the gene transcription differentially during the early 
development at day 2 and 5. No overall treatment effect is found in its transcription 
(Table 3.21)，while a significant effect is found in expression between F/TPF rats 
(p<0.05) at the early development. Its expression is found to be significantly affected 
by the age (p<0.001) and interaction (p<0.001). The significant interaction effect is 
again due to the differential response of different age groups to the TP-treatments (Fig. 
3.23): 
3.7:4. IGFBP-2 
The transcription of this binding protein gene increases progressively from day 
2 to a peak at day 10. It drops from day 15 and remains at a constant level thereafter 
(Fig. 3.24). From Table 3.22, its expression is found to be affected by the age 
(p<0.001) and the interactions (p<0.05) but not the TP-treatment. Actually，there is 
n o treatment effect in gene expression during both the early and late development. 
j u s t in opposite, the weak interaction effect (p<0.05) is found to be mainly obtained 
from the effect on its gene transcription at the age groups 1-3. 
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Fig. 3.3. Results of transcription of p-actin gene during the development of female, 
male and TP-treated female rats without normalization with cDNA concentrations in 
the RT-products. 
F/M/TPF |F/M [F/TPF [M/TPF 
| G roup1-8~A 0 ^ 0 1 A 0.001 A O^oTa 0.001 
T 0.02 T n.s. T 0.005 T n.s. ！ 0.001 i 0.01 I 0.001 I 0.001 
Group 1 - 3 A 0 ^ 0 1 A 0.001 A 0^05 A 0.001 
T 0.001 T n.s. T 0.001 T 0.001 
I 0.02 I 0.001 I n.s. I n.s. 
Group 4-8 A o B l A 0.02 A O ^ o T a 0^2* 
丁 n.s. T n.s. T n.s. T n.s. 
I n.s. I n.s. 1 n.s. I n.s. 
Table 3 1. Results of two way analysis of variance on the effects of age (2, 5, 10，15， 
20 25 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of p-actin gene without the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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Fig 3.4. Results of transcription of p-actin gene during the development of female, 
male and TP-treated female rats after normalization with cDNA concentrations in the 
RT-products. 
F/M/TPF | F / M [ F / T P F [ M / T P F 一 
iGroup 1 - 8 ~ A 0^01 ~ A 0.001 A 0.001 A 0.001 
T 0.001 T 0.02 T 0.005 T 0.001 
I 0 .001 I n .s . I 0 . 0 0 5 I 0 .001 
Group 1 - 3 ~ A 0^01 ~ A 0.001 A 0.001 A 0.001 
” T 0 . 0 0 1 T n.s. 丁 0.001 T 0.001 
I 0.001 I 0 . 0 5 丨 0.001 I 0.001 
Group 4-8 A " " " o l i o i A 0.001 A 0.001 A 0.001 
T n.s. T 0.05 T n.s. T 0.01 
I 0.001 |l n.s. |l 0.001 |l 0.001 
Table 3.2. Results of two way analysis of variance on the effects of age (2, 5，10，15， 
20 25, 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of p-actin gene after normalization with cDNA 
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Fig 3.5. Results of transcription of AR gene during the development of female, male and TP-treated 
female rats after normalization with cDNA concentrations in the RT-products. 
F/M/TPF |F/M |F/TPF |M/TPF 
Group 1-8 A 0 ^ 0 1 A 0.001 A 0.001 0.001 
丁 n.s. T 0.05 T n.s. T n.s. 
I 0.001 I 0.05 I 0.001 丨 0.05 
Group 1-3 A ！ ^ A A n.s. A n.s. 
T n s T n.s. T n.s. T n.s. ！ n.s. 丨 n.s. 丨 0.05 I 0.01 
Group 4 - 8 A 0.001 A 0.001 A 0.001 A 0.001 
T n.s. T n.s. T n.s. T n.s. 
I 0.001 I n.s. I 0-001 I 005 
Group 1 - 5 A O o ? " A " " " 0 . 0 0 1 A 0.001 A 0.001 
r T n.s. T n.s. T n.s. T 0.05 
1 n.s. 1 n.s. 1 n.s. I n.s. 
Group 6-8"""" A ^ A 0.005 A ^ A n.s. 
丁 n.s. 丁 n.s. T n.s. T n.s. 
I 0.01 |l n.s. |l 0.005 |l n.s. 
Table 3 3 Results of two way analysis of variance on the effects of age (2，5，10，15, 20, 25, 30 & 45 
d a v s x t r e a t m e n t (female, male and TP-treated female) and their interactions on the transcnption of 
A ^ gene after normalization with cDNA amount in the olfactory bulb. Results of interest were printed 
in bold. 
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Fig 3 6. Results of transcription of ERp gene during the development of female, male and TP-treated 
female rats after normalization with cDNA concentrations in the RT-products. 
F/M/TPF IF/M [F/TPF IM/TPF 
[Group 1 - 8 A 0 ^ 0 T " A ” ” “ 0 ^ 2 A 0 ^ 1 ~ A ~ 0 ^ 0 1 
T n.s. T n.s. T n.s. T n.s. 
I 0.05 I n.s. 1 n.s. I 0-05 
Group 1 - 3 ~ A " " " A ^ A ~ 0 ^ 0 5 ~ A ^ 
T n.s. T n.s. T n.s. T n.s. 
I 0.005 I n.s. 1 n.s. I 0.001 
Group 4-8 A A ~ 0 ^ 1 ~ A 0 ^ 5 A ~ O 0 0 1 ~ 
T n.s. T n.s. T n.s. T n.s. 
I n.s. I n.s. 1 n.s. 1 n.s. 
Group 1 - 5 ~ A o 1 o o r " A " " " " 0 ^ 2 A 0 . 0 0 1 A 0 ^ 5 
T n.s. T n.s. T n.s. T n.s. 
I 0.02 I n.s. 1 n.s. 1 0.001 
Group 6 - 8 ~ A ^ ~ A ~ A " " " A 
T n.s. T n.s. T n.s. T n.s. 
I n.s. I n.s. |i n.s. |l n.s. 
Table 3 4 Results of two way analysis of variance on the effects of age (2, 5, 10’ 15, 20, 25, 3 0 & 4 5 
d a y i treatment (female, male and TP-treated female) and their interactions on the transcnption of 
ERp gene after the normalization with cDNA amount in the olfactory bulb. Results of interest were 
printed in bold. 
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Fig 3.7. Results of transcription of aromatase gene during the development of female, 
male and TP-treated female rats after normalization with cDNA concentrations in the 
RT-products. 
F/M/TPF |F/M [F/TPF iM/TPF 
Group 1 - 8 ~ A 001 A 0.05 A n Z A 0.001 
T 0.02 T n.s. T 0.01 T 0.05 
I 0.02 I n.s. I 0.005 I n.s. 
Group 1-3""“A n^sl A n ! s ! ~ A n.s. A n.s. 
T n.s. T n.s. T 0.05 T n.s. 
I n.s. I n.s. I n.s. I n.s. 
Group 4-8 A 0 ^ 5 " " " A 0.05 A ^ ~ A 0.05 
丁 n s T n.s. T n.s. T n.s. 
I 0.05 I n.s. I 0.02 I 0-05 
Group 1-5 A 0.005 A ^ ~ A 0 ^ 5 ~ A 0.05 
T n.s. T n.s. T 0.05 T n.s. 
I 0.05 l n.s. I 0.02 I n.s. 
Group 6-8 A nJ . A n l . ~ A n.s. A n.s. 
T n.s. 丁 n.s. T n.s. T n.s. 
I 0.05 I n.s. I 0.05 I n.s. 
Table 3 5. Results of two way analysis of variance on the effects of age (2, 5, 10，15, 
20 25 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of aromatase gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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F i g 3 8 Results of transcription of OSCP gene during the development of female, 
male and TP-treated female rats after normalization with cDNA concentrations in the 
RT-products. 
F/M/TPF |F/M [F/TPF [M/TPF 
iGroup 1 - 8 ~ A 0 ^ 0 1 - A " " " 0 ^ 0 1 " " " " A " • “ 0 ^ 0 1 " A 0.001 — 
T 0.05 T 0.05 丁 n.s. T n.s. 
I 0.001 丨 n.s. I 0.001 I 0.01 
Group 1 - 3 A ~ 0 ^ 0 1 A ~ 0 ^ 0 1 ~ A 0.001 — 
丁 o 02 T 0.02 T n.s. T 0.02 
！ 0.001 丨 n.s. I 0.001 丨 0.001 
Group 4 - 8 ~ A 0 ^ 0 T " a ~ o H l A A ~ 0 . 0 0 5 
T n.s. T n.s. T n.s. T n.s. 
I n.s. I n.s. 丨 0.001 I n.s. 
Group 1 - 5 A M 0 1 A 0 ^ 0 1 A 0.001 — 丨 
— 丁 0.01 T 0.05 T n.s. T 0.005 
, 0.001 丨 n.s. 丨 0.001 l 0.001 
Group 6 - 8 ~ A 0^5 A ~ 0 ^ 0 1 A ~ 0 . 0 0 1 
T n.s. T n.s. T 0.05 T n.s. 
I n.s. I n.s. jl 0.005 |l n.s. 
Table 3 6 Results of two way analysis of variance on the effects of age (2’ 5, 10, 15, 
20 25 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of OSCP gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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F i g 3 9 Results of transcription of bcl-2a gene during the development of female， 
male and TP-treated female rats after normalization with cDNA concentrations in the 
RT-products. 
F/M/TPF |F/M [F/TPF — M/TPF 
|Group1-8 A 0 ^ 0 T " A ~ 0 ^ 0 T " a 0^01 ~ A 0.001 
T 0.02 T n.s. T 0.02 T 0.01 
1 0.001 I n.s. I 0-001 ‘ 0Q01 
Group 1-3 A M 0 T " A 0 . 0 0 1 A ~ A 0 . 0 1 
T 0 01 T n.s. T 0.02 T 0.005 
！ 0.001 I n.s. I 0 001 I 0-Q01 
Group 4-8 A M o T " A ~ 0 . 0 0 1 A 0001 ~ A 0 . 0 0 1 
丁 n s. T n.s. T n.s. T n.s. 
I 0.02 I n.s. I 0.001 I 0.01 
Group 1-5 A O O O T " A 0 . 0 0 1 A " " " " 0 ^ 0 1 A ~ o M ~ 
T 0 005 T n.s. T 0.005 T 0.005 
I 0.02 I n.s. I 0.001 I 0-001 
Group 6-8 A 0 ^ 0 T " a ~ 0 ^ 2 A " " " " 0 ^ 0 1 ~ A 0 ^ 0 1 ~ 
T n.s. T n.s. T n.s. T n.s. 
I 0.02 |l n.s. |l 0.005 |l 0.01 
Table 3 7 Results of two way analysis of variance on the effects of age (2, 5, 10, 15， 
20 25 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of bcl-2a gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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Fig 3 10 Results of transcription of caspase 3 gene during the development of female, 
male and TP-treated female rats after normalization with cDNA concentrations in the 
RT-products. 
F/M/TPF |F/M [F/TPF [M/TPF 
[Group 1 - 8 ~ A o Z o T ~ A ~ 0 ^ 0 1 ~ A ~ 0 ^ 0 1 A 0.001 — 
T n.s. 丁 n.s. T n.s. T n.s. 
I 0.001 I n.s. I 0.001 » Q-001 
Group 1 - 3 ~ A ^ ： ~ A ~ ^ A " " “ ^ A 0.05 — 
丁 n s T n.s. 丁 n.s. 丁 n.s. 
I 0 . 0 0 1 丨 n . s . 丨 0 . 0 0 5 I 0 - 0 0 1 
Group 4 - 8 ~ A ""“0^01 ~ A""”0^01 A 0 ^ 0 1 
丁 n s 丁 n.s. 丁 n.s. 丁 n.s. 
I 0.001 |l n.s. |l 0.001 |l 0.005 
Table 3 8 Results of two way analysis of variance on the effects of age (2, 5, 10，15, 
2 0 25 . 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of caspase 3 gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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Fig 3 11 Results of transcription of sema III gene during the development of female, 
male and TP-treated female rats after normalization with cDNA concentrations m the 
RT-products. 
F/M/TPF [F/M [F/TPF [M/TPF 
[Group 1-8 A 0001 ~ A 0 ^ 0 1 A ~ 0 ^ 0 1 A 0.001 
丁 n s 丁 n.s. 丁 n.s. 丁 n.s. 
I 0.005 丨 n.s. 丨 0.001 I 0.01 
Group 1-3 A 0.005 A 0.001 A 0.05 A 0.001 
T n s 丁 n.s. 丁 n.s. T n.s. 
I 0.005 I n.s. 丨 0.005 丨 0.01 
Group 4-8 A M01 ~ A 0.001 A 0.01 A 0.005 
T n.s. 丁 n.s. 丁 n.s. 丁 n.s. 
I n.s. I n.s. I 0.05 I n.s. 
Group 1-5 A 0001 ~ A 0.001 A ~ 0 ^ 0 1 A 0.001 — 
T n s 丁 n.s. T 0.05 T n.s. 
！ 0.005 I n.s. I 0.01 I 0.05 
Group 6-8 A 0.001 A 0.01 A 0.01 A 0.05 
T n.s. 丁 n.s. T n.s. T n.s. 
I n.s. I n.s. I n.s. |l n.s. 
Table 3 9 Results of two way analysis of variance on the effects of age (2, 5, 10，15, 
20 25 . 30 & 45 days) treatment (female, male and TP-treated female) and their 
interactions on the transcription of sema III gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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Fig 3 12 Results of transcription neuropilin-1 gene during the development of female, male 
and TP-treated female rats after normalization with cDNA concentrations in the RT-products. 
F/M/TPF |F/M [F/TPF [M/TPF 
|Group1-8 A M O I A 0 ^ 0 1 A 0 ^ 0 1 A 0.001 
T n.s. T n.s. T n.s. T n.s. 
. n n m I n.s. I 0.001 I 0.001 
Group 1-3 A 0 ^ 1 A ~ 0 ^ 0 1 A 0 ^ 0 1 A 0.001 — 
丁 n s 丁 n.s. T n.s. 丁 n.s. ！ Q.Q01 丨 n.s. 丨 0.001 丨 0.001 
Group 4-8 A M 0 1 A 0 ^ 0 1 A""”0^01 A ~ 0 ^ 0 1 
T n.s. 丁 n.s. T 0.05 丁 n.s. 
I n.s. I n.s. 1 0.001 I n.s. 
Group 1-5 A 0 ^ 0 1 " " " A C L 0 0 1 A 0 ^ 0 1 A 0.001 一 — 
丁 n s. 丁 n.s. T n.s. T n.s. 
I 0.001 I n.s. I 0.001 I 0.001 
Group 6-8 A M 0 1 A 0 ^ 0 1 A ~ 0 ^ 0 1 A 0 . 0 0 1 
丁 n.s. T n.s. T 0.005 T n.s. 
I n.s. | l n.s. | 丨 0.02 丨丨 n.s. 
Table 3 10 Results of two way analysis of variance on the effects of age (2, 5, 10，15，20，25， 
30 & 45 days) treatment (female, male and TP-treated female) and their interactions on the 
transcription of neuropilin-1 gene after the normalization with cDNA amount in the olfactory 
bulb. Results of interest were printed in bold. 
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Fig 3 13 Results of transcription plexin-1 gene during the development of female, male and TP-
treated female rats after normalization with cDNA concentrations in the RT-products. 
F/M/TPF |F/M [F/TPF IM/TPF 
iGroup 1 - 8 ~ A M 0 1 ~ A ~ 0 ^ 5 A 0 ^ 5 A 0.005 — 
T n.s. T n.s. 丁 n.s. 丁 n.s. 
I n.s. 1 n.s. 1 n.s. \ 0.02 
Group 1-3 A n l . A A ~ ^ ^ n.s. 
T n.s. 丁 n.s. T n.s. T n.s. 
I n.s. I n.s. I n.s. I n.s. 
Group 4 - 8 A 0 ^ 1 ~ A 0 ^ 0 5 A ~ f T i ： A 0 . 0 0 1 
T 0.001 丁 0.05 T n.s. T 0.001 
I 0 .05 丨 n.s. I n.s. \ 0 .02 
Group 1-5 A A A ~ 0 ^ 5 A n.s. 
j n.s. 丁 n.s. T n.s. T n.s. 
I n.s. 1 n.s. 1 n.s. 1 0.05 
Group 6 - 8 A 0^5 A A " " A 0.05 
X n.s. 丁 n.s. T n.s. T n.s. 
I n.s. I n.s. |l n.s. [1 n.s. 
Table 3 11 Results of two way analysis of variance on the effects of age (2, 5，10，15，20，25, 30 & 45 
davs) treatment (female, male and TP-treated female) and their interactions on the transcription of 
p l e x i n_! gene after the normalization with cDNA amount in the olfactory bulb. Results of interest 
were printed in bold. 
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Fig 3 14 Results of transcription of CRMP-1 gene during the development of female, male 
and TP-treated female rats after normalization with cDNA concentrations m the RT-products. 
F/M/TPF |F/M [F/TPF IM/TPF 
| G roup1-8 A 0 M ~ A ~ 0 0 0 1 A ” " " 0 ^ 0 1 " " " A 0.001 
T 0.001 T 0.005 T n.s. T 0.02 
I 0.001 \ 0.05 I 0-001 丨 0-0°1 
Group 1-3 A 0.001 A 0.001 ~ A 0.001 ~ A 0.001 
丁 0 02 T 0.02 丁 n.s. T 0.01 
| 0.001 I n.s. 丨 0.001 I 0.001 
Group 4-8 A 0^01""“ A""“0^01 ~ A""""0001"" A ~ 0 ^ 0 1 
T n s 丁 n.s. 丁 0.05 丁 n.s. 
I 0,001 丨 n.s. 丨 0 .001 丨 0 .001 
Group 1-5 A 0.001 A 0.001 A 0.001 ~ A 0^001 
T 0.005 丁 0.02 丁 n.s. 丁 0.01 
, 0.001 I 0.05 丨 0.001 丨 0.001 
Group 6-8 A 0.001 A 0 . 0 2 A 0.001 ~ A 0.001 — 
H
 T n s 丁 n.s. T 0.05 丁 n.s. 
I 0,001 |l n.s. jl 0.001 I' 0.001 
Table 3 12 Results of two way analysis of variance on the effects of age (2, 5, 10, 15，20，25, 
30 & 4 5 days) treatment (female, male and TP-treated female) and their interactions on the 
transcription of CRMP-1 gene after the normalization with cDNA amount in the olfactory 
bulb. Results of interest were printed in bold. 
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F i g 3 15 Results of transcription of CRMP-2 gene during the development of female, male 
and TP-treated female rats after normalization with cDNA concentrations in the RT-products. 
F/M/TPF I F/M [F/TPF [M/TPF 
| G roup1-8 A 0^01 ~ A ~ 0 ^ 0 1 A 0 ^ 0 1 A 0.001 — 
T n .s. T n.s. T 0.05 丁 n.s. 
！ 0.001 I 0.02 丨 0.001 I 0.05 
Group 1-3 A CL001 ~ A ~ 0 ^ 0 1 A 0.001 ~ A ~ 0 . 0 0 1 — 
T 0.005 丁 n.s. T 0.005 T 0.02 
I n.s. I n.s. I n.s. I n.s. 
Group 4-8 A A 0.001 A 0 . 0 5 A 0.001 
T n s. 丁 n.s. T n.s. 丁 n.s. 
I 0.005 丨 0.02 丨 0.01 I 0.05 
Group 1-5 A 0^01 ~ A ~ 0 ^ 0 1 A 0 . 0 0 1 A 0 . 0 0 1 
T n.s. 丁 n.s. T n.s. T n.s. 
, 0.001 I 0.02 丨 0.001 丨 n.s. 
Group 6-8 A 0 ^ 2 A 0.02 A 0.05 A n.s. 
T n.s. 丁 n.s. T n.s. 丁 n.s. 
I n.s. I n.s. I n.s. |l n.s. 
Table 3 13 Results of two way analysis of variance on the effects of age (2, 5, 10，15，20, 25， 
30 & 45 days) treatment (female, male and TP-treated female) and their interactions on the 
transcription of CRMP-2 gene after the normalization with cDNA amount in the olfactory 
bulb. Results of interest were printed in bold. 
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Fig 3 16 Results of transcription of CRMP-3 gene during the development of female, male and TP-
treated female rats after normalization with cDNA concentrations in the RT-products. 
F/M/TPF |F/M [F/TPF [M/TPF 
iGroup 1-8 ~ " " “ 0 ^ 0 1 ~ A ~ 0 ^ 0 1 A ~ 0 ^ 0 1 A 0.001 
丁 0 0 0 1 丁 0 . 0 2 T 0 . 0 0 1 T n.s. 
I 0.001 I 0.01 丨 0.001 丨 0.001 
Group 1-3 A 0 ^ 2 A""“0^01 A"""KI. A n . s . 
T 0.02 T 0.02 丁 0.005 T n.s. 
, 0.01 i 0.02 丨 n.s. I 0.01 
Group 4-8 A M 0 1 A " • “ 0 ^ 0 1 A ~ o B l A 0 . 0 0 1 
T 0 05 丁 n.s. 丁 0.005 丁 n.s. 
I 0.005 I n.s. I 0.001 I n.s. 
Group 1 - 5 A 0 ^ 5 1 A 0 . 0 0 1 A ~ 0 ^ 0 1 A 0 . 0 0 1 一 
T o 05 丁 0 . 0 5 丁 0 . 0 1 丁 n.s. 
, 0 001 I 0.005 \ 0.05 I 0-005 
Group 6-8 A M O l ~ A ~ T o 5 ~ ^ 0 0 0 1 A 0 : -
T o 05 丁 n.s. 丁 0.005 丁 n.s. 
, 0.05 I n.s. I 丨 0.001 |l n.s. 
T a b l e 3 14 Results of two way analysis of variance on the effects of age (2, 5，10’ 1 5 ， 2 0 ， 2 5 ， 4 5 
dav ? treatment (female, male and TP-treated female) and their interactions on the transcnption of 
S p - 3 gene after the no誦lization with cDNA amount in the olfactory bulb. Results of interest 
were printed in bold. 
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F i g 3 17 Results of transcription of CRMP-4 gene during the development of female, male 
and TP-treated female rats after normalization with cDNA concentrations in the RT-products. 
F/M/TPF 1F/M 丨 F/TPF [M/TPF 
iGroup 1-8 A 0 ^ 0 1 A ~ 0 ^ 0 1 A ~ 0 ^ 0 1 " " “ A 0.001 — 
T n s T n.s. 丁 n.s. T n.s. 
, 0 ,001 I n.s. 丨 0 .001 丨 0 .001 
Group 1-3 A ~ A 0.001 A 0.001 ~ A 0.001 
T n s 丁 n.s. 丁 0.05 丁 n.s. 
, 0,02 丨 n.s. 丨 0.01 I 0.02 
Group 4-8 A A 0.001 ~ A 0 .001""“ A 0-001 
H
 T 0 . 0 0 1 丁 n.s. 丁 0 . 0 0 1 丁 0 . 0 2 
| 0.005 I 0.05 I 0-001 I n.s. 
Group 1-5 A 0^01 ” A " " " 0 ^ 0 1 ~ A ~ 0 ^ 0 1 A 0.001 
T n s 丁 n.s. T n.s. T n.s. 
I 0.001 I n.s. I 0.005 I 0.001 
Group 6-8 A ^ A - f T i ： A 0 . 0 2 A 0.05 
T n s 丁 n.s. T 0.05 T n.s. 
！ 0,005 |l n.s. |l 0.02 |丨 0.005 
Table 3 15 Results of two way analysis of variance on the effects of age (2, 5, 10, 15, 20, 25, 
30 & 45 days) treatment (female, male and TP-treated female) and their interactions on the 
transcription of CRMP-4 gene after the normalization with cDNA amount in the olfactory 
bulb. Results of interest were printed in bold. 
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Fig 3 18. Results of transcription GAP-43 gene during the development of female, 
male and TP-treated female rats after normalization with cDNA concentrations in the 
RT-products. 
F/M/TPF |F/M [F/TPF [M/TPF 
Group 1 - 8 " " " A 0.001 A 0 ^ 0 1 A 0 ^ 0 1 A 0.001 
j n.s. T n.s. T n.s. 丁 n.s. 
I 0.01 I n.s. I n.s. I 0.005 
Group 1 - 3 A ^ A K I . A n.s. A n.s. 
r 丁 n.s. 丁 n.s. 丁 n.s. T n.s. 
I n.s. 丨 n.s. I n.s. 丨 n.s. 
Group 4 - 8 A 0.001 A 0 ^ 0 5 A ~ 0 ^ 0 1 A ~ 0 0 0 5 
T 0.05 T n.s. T n.s. 丁 0.02 
I 0.001 I 0.001 |l n.s. |l 0.001 
Table 3 16. Results of two way analysis of variance on the effects of age (2, 5, 10，15, 
20 25 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of GAP-43 gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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Fig 3 19 Results of transcription OMP gene during the development of female，male 
and TP-treated female rats after normalization with cDNA concentrations m the RT-
products. 
F/M/TPF |F/M [F/TPF [M/TPF 
|Group1-8 A O O O T " A 0 ^ 0 1 A""""0^01 A 0.001 — 
T 0.05 T n.s. T 0.05 T 0.01 
I n.s. 丨 n.s. I n.s. 丨 0.05 
Group 1-3 A 0.001 A 0.001 ~ A 0.001 A 0.05 
T n.s. 丁 n.s. T n.s. T n.s. 
I 0.05 I n.s. I 0.005 I n.s. 
Group 4-8 A 0.001 A 0.001 ~ A 0 . 0 0 1 A 0^001 
T n.s. 丁 n.s. T n.s. T 0.05 
I n . s . 丨 丨 n.s. |l n.s. jl 0.05 
Table 3 17 Results of two way analysis of variance on the effects of age (2, 5, 10，15, 
20 25 . 30 & 45 days) treatment (female, male and TP-treated female) and their 
interactions on the transcription of OMP gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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Fig. 3.20. Results of transcription G0if gene during the development of female, male 
and TP-treated female rats after normalization with cDNA concentrations in the RT-
products. 
F/M/TPF |F/M [F/TPF |M/TPF 
IGroup 1 - 8 A M 0 1 A 0 ^ 0 1 A 0 ^ 0 1 A 0.001 — 
T n s 丁 n.s. 丁 n.s. 丁 n.s. 
I 0.05 I n.s. I 0-02 l 0.05 
Group i - 3 A M01 ~ A 0 ^ 0 1 A ~ 0 ^ 0 1 A 0.001 
T n.s. 丁 n.s. T n.s. T n.s. 
I 0.05 I n.s. I n.s. I 0.02 
Group 4-8"•“ A 0^01 ~ A ~ 0 ^ 0 1 A ~ 0 ^ 0 1 A 0 ^ 0 1 
T n.s. 丁 n.s. T n.s. 丁 n.s. 
I n.s. I n.s. |l 0.05 |l n.s. 
Table 3 18 Results of two way analysis of variance on the effects of age (2，5, 10，15, 
20，25，30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of G0if gene after the normalization with cDNA 
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Fig. 3.21. Results of transcription SP gene during the development of female, male and 
TP-treated female rats after normalization with cDNA concentrations in the RT-
products. 
F/M/TPF F/M F/TPF M/TPF 
Group 1-8 A 0.001 A 0.01 A n.s. A 0.02 
T n.s. T n.s. T n.s. T n.s. 
I n.s. I n.s. I n.s. I n.s. 
Group 1-3 A 0.01 A 0.01 A 0.02 A n.s. 
T n.s. T n.s. T n.s. T n.s. 
I n.s. I n.s. I n.s. I n.s. 
Group 4-8 A 0.01 A 0.005 A n.s. A 0.05 
T n.s. T n.s. T n.s. T n.s. 
I n.s. I n.s. I n.s. I 0.05 
Table 3.19. Results of two way analysis of variance on the effects of age (2, 5, 10, 15, 
20, 25, 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of SP gene after the normalization with cDNA amount 
in the olfactory bulb. Results of interest were printed in bold. 
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Fig. 3.22. Results of transcription GnRH gene during the development of female, male 
and TP-treated female rats after normalization with cDNA concentrations in the RT-
products. 
F/M/TPF |F/M [F/TPF |M/TPF 
Group 1 - 8 A 0^01 A ~ 0 ^ 0 1 A 0 ^ 0 1 A~0.001 
T n.s. T n.s. 丁 n.s. 丁 n.s. 
I 0.001 I n.s. 丨 0.005 I 0.001 
Group 1-3 A 0 . 0 0 5 ~ A 0 0 0 1 A n Z A 0.02 
T n s. 丁 n.s. T n.s. T n.s. 
I Q.0Q1 I n.s. I 0.02 I 0.001 
Group 4 - 8 A 0001 A 0 ^ 0 1 A 0 ^ 0 5 A""”0.05 
T 0.05 丁 n.s. T 0.01 T n.s. 
I n .s. I n.s. I n.s. |l n.s. 
Table 3.20. Results of two way analysis of variance on the effects of age (2, 5，10，15, 
20 25 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of GnRH gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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Fig. 3.23. Results of transcription mGluR2 gene during the development of female, 
male and TP-treated female rats after normalization with cDNA concentrations in the 
RT-products. 
F/M/TPF |F/M [F/TPF [M/TPF 
Group 1 - 8 ~ A 0 ^ 0 1 A 0 ^ 0 1 ~ A ~ 0 ^ 0 1 A 0.001 — 
丁 n s 丁 n.s. T n.s. 丁 n.s. 
I 0,001 丨 n.s. 丨 0.001 丨 0.001 
Group 1 - 3 " " " A 0 ^ 0 5 A 0 0 0 5 ~ A A 0.02 “ 
T n s 丁 n.s. 丁 0.05 T n.s. 
I 0.001 丨 n.s. i 0.001 丨 0.001 
Group 4 - 8 A 0^01 ~ A 0 ^ 0 1 A ~ 0 ^ 0 1 A 0 . 0 5 
T n.s. 丁 n.s. 丁 n.s. T n.s. 
I 0.01 |l n.s. | 丨 0.001 |l 0.05 
Table 3.21. Results of two way analysis of variance on the effects of age (2，5, 10，15， 
20 25 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription ofmGluR2 gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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Fig. 3.24. Results of transcription IGFBP-2 gene during the development of female, 
male and TP-treated female rats after normalization with cDNA concentrations in the 
RT-products. 
F/M/TPF [F/M [F/TPF [M/TPF 
Group 1 - 8 " " " A 0 M ~ A 0 ^ 0 1 A~OJOOI A 0.001 — 
T n.s. 丁 n.s. T n.s. T n.s. 
I 0.05 丨 n.s. 丨 0.02 I 0.05 
Group 1-3""""A 0^01 ~ A " " 0 ^ 0 1 A ~ 0 ^ 0 1 A 0.001 
r t n.s. 丁 n.s. T n.s. 丁 n.s. 
I 0.05 I n.s. I n.s. > 0.01 
Group 4 - 8 ~ A 0 0 0 5 A " " “ 0 ^ 1 A ~ 0 ^ 0 1 A ~ 
j n.s. 丁 n.s. T n.s. T n.s. 
I n.s. 1 n.s. |l 0.02 |l n.s. 
Table 3.22. Results of two way analysis of variance on the effects of age (2, 5，10，15， 
20 25 30 & 45 days), treatment (female, male and TP-treated female) and their 
interactions on the transcription of IGFBP-2 gene after the normalization with cDNA 
amount in the olfactory bulb. Results of interest were printed in bold. 
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4. Discussion 
4.1. Quantitation of cDNA and normalization of PCR results 
The aim of the present investigation is to examine the transcription of 
development related genes in the olfactory bulb of rats by RT-PCR. Expression of 
housekeeping gene such as P-actin is known to be essential in maintaining the 
cytoskeleton (structural element) of cells. In many studies, housekeeping genes like p-
actin, cyclophilin and GAPDH are used to normalise the PCR data as their gene 
transcriptions are assumed not affected by any factor, e.g. treatments or age. 
However, from Table 3.1 and 3.2 (refer to Results), significant differences of p-actin 
expression are found between the results without and with the correction of cDNA 
concentrations. The results clearly indicate that the transcription of p-actin gene is 
affected by age，sex and treatment with TP. It implies that housekeeping gene such as 
P-actin cannot be used as a parameter to correct the data in the present study 
especially when TP-treatment is involved. 
In present study, the cDNA concentrations of each sample are quantitative 
determined by using the fluorescence dye i.e. OliGreen for ssDNA quantitation 
(Molecular Probes, USA). And the cDNA concentration of each sample are used for 
normalization purpose. For the determination of cDNA concentrations, sample 
measurement was triplicated to ensure the precision of the assay. Concentration of 
each sample was read from the standard curve constructed with pooled cDNA samples 
of this study (Fig 3.1). The cDNA concentrations obtained from OliGreen quantitation 
were directly used to correct the unequal amount of cDNA added into the subsequent 
PCR. Under the assumption that efficiency of all the RT-reactions are more or less the 
same，it is theoretically a more reliable approach for normalization of unequal amount 
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of cDNA added into individual PCR tubes. The standard curve of cDNA 
determination shows a linear relationship from 30 ng to 200 ng of total RNA and all 
the samples fall in the range of the standard curves. 
4.2. Sexual differentiation related genes 
Receptors of steroid hormones increase gradually in the rat brain from neonatal 
stages to sexual maturity. Although many factors are involved in altering the 
responsiveness of the brain to steroid hormones during the postnatal development 
stages, the ontogeny of receptors in brain may also be responsible at least part of this 
process (Kato, 1980). To address the question whether expressions of sex steroid 
receptors are the determining factor for the sexual differentiation, AR and ERp genes 
expressions are examined in this study. To our surprise, expression of both AR and 
ERp genes are only found to be significantly affected by age but not affected by 
treatment (Table 3.3 and 3.4). In this study, ERp, but not the well-known ERa, is 
found to be the only estrogen receptor subtype expressed in the rat olfactory bulb is 
confirmed (Kuiper and Gustafsson, 1997; Kuiper et al, 1997). 
No overall treatment effect (F/M/TPF) is found on the expression of AR gene 
(Table 3.3). Sex difference is only found at the significant levels of p<0.05 and the 
TP-treatment is not affecting the expression of AR gene. In Fig. 3.5，a progressive 
increase of AR gene expression during the development of rat OB is illustrated. There 
is，however, not much change during the early development and significant change is 
only observed at day 20 to day 45. It indicates an increasing AR transcription from the 
peripubertal stage to the adulthood in rats. 
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In case of ERp, only an age effect is found in its transcription, and it can be 
seen that the change is again observed at the peripubertal stage of day 25 and day 30 
(Fig.3.6). No treatment effect can be found in the expression of ERp. It is supposed 
that changes in expression of ERp gene are age dependent and might play a role at the 
late development of the rat OB as in that case of AR. Even though no sexual 
differences in terms of ERp gene expression is found in this study, it is not necessary 
contradictory to the finding of estrogen-dominant sexual dimorphic olfactory bulb 
differentiation. In this study, the expression of aromatase gene was also examined. 
From morphological studies, a distinct sexual dimorphic AOB in the rodents is 
reported (Perez-Laso et al., 1994; Valencia et al., 1986). It is found that male rats 
present larger volume and number of neurons in the AOB than females and its 
differentiation is supposed to be similar to the SDN. Masculinization of the accessory 
olfactory bulb in the male is under the control of high local concentration of estrogen, 
and is produced by the conversion of testosterone to estrogen by aromatase (Gorski, 
2000; Guillamon and Segovia, 1997). 
In this study, the results indicate that the expression of aromatase gene is age 
dependent. All the differences are due to the changes in transcription at the late 
development. No age effect is observed among rats at the age of \ 5 & 10 days. It 
may imply that aromatase transcription may not play an important role in the early 
development. Also, we found that its expression is under the effect of TP-treatment, 
but there is no sexual difference as predicted. It is a possible that the availability of 
aromatase in the developing OB may be affected by the translation of this gene. 
However, even though no sexual difference can be found in its transcription, the TP-
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treatment providing an extra-sources of substrate for the increase in its transcription, 
especially in the early development. In this case, it is possible that the sexual 
differences of the accessory olfactory bulb may not due to the availability of aromatase 
in this area (see Balthazart and Ball, 1998; Roselli et al., 1997). In case of SDN, in 
the female, high concentration of a-fetoprotein lowers the availability of high free 
estrogen to these tissues leads to the development of female type SDN (Doehler, 
1991). The differentiation of the accessory olfactory bulb may be under the control of 
a similar mechanism. As there is no sexual difference in the expression of ERp, a 
putative membrane-bound estrogen targeting protein, i.e. OSCP (Zheng and Ramirez, 
1999a，b) is examined. Actions through non-genomic mechanisms, after binding to 
this protein independently from the nuclear estrogen receptors, however, require 
pharmacological concentrations (0.1-100 \x\Jl) of estrogens (Sawada et al., 1998). The 
physiological role of OSCP requires further study. In this study, gene expression of 
OSCP is found to be not only affected by age, but also by sex. Especially in the early 
development, male rats seem to have a higher expression of OSCP gene than in female 
rats. Early stage postnatal TP-treatment seems to have an interaction effect at the age 
of day 2 to day 10 between the male and the TP-treated female rats. No significant 
difference is observed in the late development. So, whether OSCP plays a role in the 
sexual differentiation during the early development of the rat OB, which including the 
critical period, requires further investigation. 
4.3. PCD related genes 
As described in the pervious section, female rats have a smaller SDN than the 
male. A small SDN indicates a lower number of neurons in these hypothalamic nuclei 
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(Doehler, 1991). The whole picture on how gene expressions leading to elimination of 
dying neurons by PCD is still a mystery (Davis et al., 1996). It seems to have a very 
diversified mechanisms in controlling various kinds of PCD in the CNS. It is well 
known that up to 50% of neurons are lost in some brain regions during its 
development (Merry and Korsmeyer, 1997) to create more space and to allow 
adequate nutrients for further differentiation and development of surviving neurons. 
And such lost in neurons is found to be as a result of PCD. To consider the 
involvement of PCD during the maturation of the olfactory bulb, bcl-2a and caspase3 
gene expressions are studied, 
The proto-oncogene bcl-2 is now known to belong to a growing family of 
apoptosis regulatory gene products, which may either be death antagonists (Bcl-2, Bcl-
XL) or death agonists (Bax, Bad) (Kroemer, 1997; Reed, 1994). Bcl-2 itself, is an 
integral intracellular membrane protein that inhibits PCD induced by multiple insults in 
a wide variety of cell types (Kroemer, 1997). Bcl-2 suppresses death of cells due to 
growth factor withdrawal and also due to glucose withdrawal, membrane peroxidation, 
and free radical-induced damage, suggesting that it acts on a central step in apoptosis 
(Zhong et al., 1993). It is also suggested that Bcl-2 acts on the upstream of ICE/CED-
3 proteases and inhibits apoptosis by preventing their posttranslational activation 
(Srinivasan et al., 1996). It is known that dimerization is involved in Bcl-2 function 
(Yang et al, 1995), but it is not clear whether apoptosis is prevented by homodimers 
like Bcl-2/Bcl-2 (Oltvai et al., 1993) or heterodimerization with related factors such as 
Bax is required (Sedlak et al., 1995). In present study, bcl-2a gene expression is 
found to be affected by the age, treatments and the interaction (age x treatment) but 
not by sex as reported earlier (Wong et al., 2000). However, this discrepancy may be 
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due to the different age of the animals examined or even the substrain of S.D. rats used 
in these two studies. From the pattern of its expression (Fig. 3.9), bcl-2a gene is 
found to be most highly expressed during early development at day 5 and falls to a 
minimum at day 20. This may indicate that bcl-2a plays a role in regulating the 
process of PCD during the early development of rat OB. Developmental profile of the 
transcription of bcl-2a in the mice suggests a progressive decline of its expression 
from the maximum level at E15 to the adult levels (Abe-Dohmae et al., 1993). The 
expression of the bcl-2 gene is usually not upregulated by activation events, but under 
a kind of negative regulation. It is well known that pro- and contra-apoptotic 
members of the bcl-2 gene family proteins work together in regulating the process of 
PCD (Fadeel et al., 1999). Overexpression of bcl-2 gene in cultured neurons as well as 
in in vivo systems prevents apoptosis induced by withdrawal of nerve growth factors. 
High levels of bcl-2a gene transcription during the early development of the OB 
suggests the involvement of bcl-2a gene transcription in early development of the 
olfactory bulb. (Oppenheim, 1991). 
PCD is under the control of complex events that includes the activation of a 
number of apoptotic genes. Caspase 3 is the enzyme that involved in the process of 
apoptosis. Caspase 3，a member of the caspase gene family, its activation is suggested 
to be the final process in the execution of cell death (Harvey and Kumar, 1998). It is, 
therefore, interesting to see its expression profile during the OB development. From 
this study, the expression of caspase 3 gene is affected by the age and their interaction, 
but not by treatments. There is a gradual decrease in the transcription of caspase 3 
gene from day 10 to day 20. Upregulation of its expression during early development 
of the OB is evidenced in this study. There are more than 10 members in the caspase 
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family, and there is good evidence that the caspases are capable of activating each 
other (Takahashi et al., 1997). Also, caspase activation appears to be regulated by 
members of bcl-2 gene family. There are also intrinsic inhibitors of cellular caspases, 
from the gene family of inhibitor of apoptosis (IAP) such as X-linked IAP (XIAP) and 
neuronal apoptosis inhibitory proteins (NAIPs) (Mesner and Kaufmann, 1999). 
Further investigation is needed to assure their roles in the development of the OB. 
4.4. Axon guidance molecules and related genes 
Neurons extend their axons over a long distance, bypassing billions of potential 
but inappropriate synaptic targets before terminating in the correct site and recognizing 
the appropriate targets. The topological relationships of neurons within a functional 
neural circuit are so complex that a special set of mechanisms for the proper 
development is required. In essence, these mechanisms involve recognition of 
environmental cues by the grow cone of growing axons. The pathways along which 
axons grow provide a large number of diverse molecular cues to guide axons to their 
targets, and the axons possess exquisitely specific receptors to recognize and to 
interpret these cues (Sanes and Jessell，2000). 
Semaphorins are axon guidance molecules. Sema III/Coll-1 belongs to the 
semaphorin family of proteins. It was suggested to have a functional role in neuronal 
development by inhibiting growth cone extension toward unwanted directions in a 
receptor-mediated process (Goodman, 1996). Results of this study show that sema III 
gene expression increases from day 2 to a maximum at day 5 and then falls gradually to 
day 30，with an increase at day 45. It seems that it is highly expressed during the early 
development, especially at day 2 and day 5. It may imply that many axons undergo 
growth cone collapse when there is an increase in sema III gene transcription. Sema 
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Ill is supposed exert its function by preventing premature entry of sensory axons into 
their target (Kobayashi et al., 1997). A decrease in sema III gene expression in later 
stage allow more olfactory nerve axons entering the mature olfactory bulb. Other than 
the developing OB, sema III gene is also found to be expressed in OB of adult rats. 
The expression of sema III gene was upregulated at day 45. It is well known that 
turnover of sensory olfactory neurons in the olfactory neuroepithelium continues 
throughout life, because it has retain its capacity to replace dying neurons with new 
neurons formed by cell division from stem cells in the basal region of the epithelium 
(Pasterkamp et al., 1998). These new olfactory neurons extend axons penetrating the 
cribriform plate and entering the CNS, where they continue to grow through the 
growth-permissive nerve layer of the olfactory bulb until they have entered the 
glomerular neuropil, where they stop growing to form synapses on the second-order 
olfactory neurons (see Fig. 4.1). Sema III induces the collapse of the newly formed 
olfactory axonal growth cone and prevents them from invading the olfactory bulb. 
Sema IV, another member of the semaphorin family acts as a repellent for olfactory 
bulb axons and an antirepellent for olfactory axons, allowing them to enter the bulb 
even in the presence of a high concentration of sema III in their target territory (de 
Castro et al., 1999). All the factors responsible for these actions have not been 
identified but it is interesting to see whether it is a member of the semaphorin gene 
family. In this study, sema III gene transcription is only affected by age and not by the 
treatments. No sexual difference or effects of neonatal TP-treatment is observed in its 
transcription. The interaction effects between age and the treatment are mainly due to 
the difference in sema III gene expression of TP-treatment female rat at early 
development stages. TP-treatment enhances its expression at day 2 while suppresses it 
at day 5. 
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Fig. 4.1. Illustration of the anatomical relationships in the primary olfactory system. 
The cell bodies of olfactory receptor neurons are located in the olfactory epithelium of 
the nasal cavity and project their axons through the cribriform plate into the olfactory 
bulb glomeruli, where they terminate on the processes of second-order olfactory 
neurons: the mitral, tufted, and periglomerular cells. (Modified from Pasterkamp et al., 
1998) 
Neuropilin is a sema Ill-binding protein and it mediates sema Ill-induced 
chemorepulsive signals to the dorsal root ganglion (DRG) neurons (He and Tessier-
Lavigne，1997). This results also suggest that neuropilin is either a receptor or a 
component of a receptor complex for sema III. Kitsukawa and colleagues (1997) has 
shown that the DRG growth cones with neuropilin mutants were protected from the 
sema Ill-induced growth cone collapse. It indicates that neuropilin is either a 
functional receptor or an indispensable component of a receptor complex for the 
growth cone repellent sema III (Kitsukawa et al., 1997). So in present study, we have 
examined the expression profile of neuropilin-1 gene during the development of rat 
OB. Referring to the results, it can be found that neuropilin-1 gene is highly expressed 
in the early development, i.e. day 2 to day 5, and decreases in the later stages, which is 
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similar to that of sema III gene. Also, as in sema III gene, its expression is affected by 
the age but not by the sex and treatment. So we suppose that sema III and neuropilin-
1 gene expressions are correlated and may play a role in guiding the olfactory neuron 
axons to their target during the development of the OB. Interestingly, there is a 
treatment effect in the expression of neuropilin-1 gene similar to that of sema III gene, 
which the TP-treatment enhances the expression in day 2 but suppresses it in day 5. It 
is, however, not known if there is any correlation. 
A second semaphorin-binding protein, plexin-1，has been identified more 
recently (Comeau et al., 1998). Neuropilin-1 can bind to sema III alone, but it is also 
found that neuropilin-1 and plexin-1 form a complex with enhanced affinity for Sema 
III (Takahashi et al.? 1998). This suggests that a neuropilin-1/plexin-1 complex, rather 
than neuropilin-1 alone, forms physiologically relevant growth cone binding sites for 
Sema III. Previous work had indicated that while neuropilin-1 is necessary and 
sufficient for growth cone binding of Sema III, neuropilin-1 itself does not transmit a 
signal to the cytoplasmic domain of the growth cone (Nakamura et al., 1998; 
Takahashi et al., 1998). It is because the intracellular domain of neuropilin-1 is short 
and contains no motifs known to participate in signal transduction (Kawakami et al., 
1 9 9 6 ) . Actually, plexin-1 is found to be a signal transducer for the neuropilin-1/Sema 
III complex (Takahashi et al., 1999). It also supposed that all semaphorin signals may 
be mediated via plexins. Soluble class 3 semaphorin utilizes neruopilins as high-affinity 
binding intermediates in order to access a more general plexin transduction cascade. In 
the present study, however, plexin-1 shows no special expression pattern during the 
OB development although it is age dependent. So it seems that the expression of 
plexin-1 gene may not be a limiting factor controlling the process of growth cone 
collapse during the development of OB. It can be explained that plexin-1 is expressed 
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in excess during the development or the difference may be reflected at the level of 
translation. Also, there is no significant sex and treatment effect in the transcription of 
plexin-1 gene. Actually, the age effect is due to the differences in the later stage of the 
development, which there is also sexual difference and treatment effect between the 
male and TP-treated female rats. 
The intracellular mechanisms underlying Sema Ill-induced growth cone 
collapse are not fully understood. A family of CRMP is implicated, but its mechanism 
of action is ill-defined (Wang and Strittmatter, 1996，1997). In chicken, CRMP-62 
(CRMP with a M r of 62 kDa) is supposed to participate in the intracellular signaling 
cascade for the sema Ill-induced growth cone collapse (Goshima et al., 1995). It was 
found that the rat protein CRMP-2 has significant sequence similarity with CRMP-62, 
indicating that multiple CRMP-related genes may exist in mammals (Minturn et al., 
1995). In this study, we have examined the transcriptions of CRMP-1 to 4 genes. 
They are highly related with one another by sequence, but they are derived from 
separate genes, each of the CRMP genes appears to produce one unique transcript. 
From the results, CRMP-1 gene expression increases from day 2 to day 5 and 
decreases to a low level during the late development stages. Its expression is not only 
affected by age, but sex also, which the difference is mainly coming from the early 
development, i.e. day 5. Also there are interaction effects, especially between day 30 
and day 45. For CRMP-2 and CRMP-4 genes, we found that their expression patterns 
are similar, with maximal expression in early postnatal stages, and with sharp 
downregulation postnatally. The only treatment effect found in CRMP-2 gene 
expression is the transcription of this gene at the early development of the OB. TP-
treatment seems to suppress its expression during the early development in the OB. 
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Again for CRMP-4 gene, no overall treatment effect can be found, while differences of 
transcription can be found between the TP-treated female and control animals at the 
late development. From the results, CRMP-1, 2 and 4 genes are expressed highly in 
the neonatal rat OB which is similar with that of neuropilin-1 and sema III. This 
indicates that they may play an important role with neuropilin-1 in sema Ill-induced 
growth cone collapse during the early stage of OB development. However, the 
expression of CRMP-3 gene is unique. It is transcripted highly during the early time, 
but also during the late development stages, i.e. day 25 to day 30. The persistent 
expression of CRMP-3 gene in adult OB suggests that it may function in the adult 
brain as well as during brain development. In day 5，the expression of CRMP-3 gene 
in male rats is much higher than that of females, so makes the sex difference 
significant. Differences in expression are found between control female rats and TP-
treated female (F/TPF), seems that TP-treatment enhances its expression. Previous 
studies indicated that chick CRMP-62 is necessary for a G-protein-mediated 
transduction of an extracellular collapsin signal into growth cone collapse (Goshima et 
al.，1995). However, the actual mechanism is not yet known. To respond to a 
multitude of semaphorins, it is conceivable that neurons require intracellular 
mechanisms to differentiate these signals. The presence of the CRMP gene family may 
provide this diversity. The simplest explanation for the existence of the CRMP gene 
family is that different isoforms of CRMP are associated with transduction of signals 
from different semaphorins. A second explanation is that different CRMPs may couple 
to various intracellular events stimulated by separate semaphorins. A third explanation 
is that multiple CRMPs may mediate the responses for the semaphorin family as well as 
other collapsing factors. Fig. 4.2 presents the model of Sema III/neuropilin-1-mediated 
growth cone signaling. 
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Fig. 4.2. Model of Sema III/neuropilin-1-mediated growth cone signaling associated 
with Plexin-1 and CRMPs. (Modified from Nakamura et al., 1998) 
4.5. Olfactory marker protein genes 
The olfactory system is unique in the CNS since it is a site of having continuing 
neurogenesis throughout the life, by replenishing its neuronal cells from the stem cells. 
The immature neuron axons grow towards the olfactory bulb and form synapses in the 
bulb. These immature olfactory neurons express the GAP-43. This protein has been 
implicated in neural d e v e l o p m e n t and synaptic plasticity, so it is understandable that it 
is expressed solely in the immature neurons. It is reported that throughout the rat 
brain as a whole, levels of GAP-43 are highest during the first postnatal week, and 
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then fall more than 90% in the next few weeks (Jacobson et al., 1986). Our results 
agree with this finding. It is demonstrated in our results that, the expression of GAP-
43 gene remains high in the early development stage, i.e. day 2 to day 10 and falls in 
"the later stage. However, its expression did not drop to the low level as described. 
Since the olfactory system is unique, which remains the ability to form new neurons, it 
is conceivable that continued expression of GAP-43 results in an enhanced capacity of 
olfactory neurons to survive injury, inflicted on these neurons throughout life by 
noxious stimuli that enter the nasal cavity. On the other hand, GAP-43 may be 
expressed continually to play a role in the functional plasticity in the adult olfactory 
bulb (Jacobson et al., 1986). 
It was reported that transcription of GAP-43 gene in the postnatal brain is 
sexually dimorphic and it positively correlated with the level of serum testosterone. 
GAP-43 and estrogen receptor are present in similar regions of the cerebral cortex, bed 
nucleus of the stria terminalis and medial preoptic nucleus, testosterone modulation of 
GAP-43 may be an estrogen receptor-mediated event (Shughrue and Dorsa, 1993). 
Similar with the SDN of the medial preoptic area, the sexual dimorphism is induced by 
the local concentration of estrogen. Interestingly, it is found that GAP-43 mRNA 
concentrates in the SDN-POA region during postnatal life and the level of GAP-43 
mRNA is higher in males than in females and can be modulated by changes in gonadal 
steroid hormone levels. Whether the hormone-dependent changes in the size of the 
SDN-POA and intensity of GAP-43 mRNA hybridization signal are related is currently 
unknown. These findings, however, suggest that the differential action of gonadal 
hormones or their metabolites may establish a sex dimorphism in GAP-43 gene 
expression and that this difference may be one of those factors involved in determining 
the phenotype of neuronal connections. However, from our results, no significant sex 
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difference in GAP-43 gene expression can be found during the development of OB. It 
seems that this result is different from the findings on the SDN (Shughrue and Dorsa, 
1993). Actually, there is a treatment effect in the late development stage, it mainly 
comes from the difference between the male and TP-treated female rats, especially at 
day 15. But it is not known if there is any significance. 
OMP is found to be expressed reciprocally to GAP-43, i.e. in matured 
olfactory neurons, and can be used as an index for the maturation of olfactory neurons. 
From previous studies, OMP does not present in immature cell, but with increasing 
expression in growing neurons and becomes a maximal with maturation (Verhaagen et 
al.，1989). From our results, OMP gene expression is significantly affected by age but 
not by sex. The expression pattern of OMP gene is as expected, remains low in the 
early period of the OB development and becomes high in later postnatal stages. By 
comparing the expression patterns of GAP-43 and OMP genes (Fig. 3.18 & 3.19), 
their expressions are found to be reciprocal as described in Verhaagen et al., (1989). It 
is believed that the OMP expresses solely in mature neurons. Therefore, from its 
expression pattern, we suppose that the olfactory bulb becomes mature from day 25. 
From the statistic, its expression is affected by TP-treatment. The differences in OMP 
gene expression are found between the TP-treated female and control rats. In most 
age groups, except day 30，TP-treatment seems to have a suppressing effect in OMP 
gene expression. However, it does not bring the expression to the level of control 
males which have no difference found with control females in present study. It means 
that the treatment does affect OMP gene expression but not reflects the incidence in 
the sexual dimorphism. 
It is suggested the olfactory signal-transduction begins when odor molecules 
interacted with odor receptors (Vassar et al., 1993). The special G-protein for 
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olfactory formation, G0if is believed to be the G-protein to transduce the signals from 
the receptors to the AC and PLC in turn leading to the production of cAMP and IPs 
(Reed et al., 1992). From morphological studies, antibodies to G0if and type III AC 
hardly labeled the vomeronasal structures, axons and dendrites of the main olfactory 
organ but with one exception; olfactory axons and possible their terminals, glomeruli in 
the olfactory bulb are labeled (Menco et al, 1994). There is also evidence for the 
expression of presumably Ca2+/calmodulin-sensitive and partially characterized type 
VIII AC (Pieroni et al., 1993) in glomeruli of the OB (Matsuoka et al., 1992). G0if 
acts as signal transducers of both Ca27calmodulin-sensitive and Ca27 calmodulin-
insensitive ACs (Pieroni et al., 1993). In the other words, it can conceivably interact 
with different ACs. G0if is, however, restricted to maturing and mature receptor cells 
that respond selectively to odors (Gesteland et al., 1982). Refer to the present results 
(Fig. 3.20), the expression pattern of G0if gene fluctuates during the development. 
Increase in G d f gene expression is observed at day 15, 25 and 45 than the rest of time. 
Results of statistic show that its expression is significantly affected by age and their 
interactions at some stages but not by and treatments (including sex). It may suggest 
the expression of G0if gene in processing of odors in both sexes is more complex than 
expected. 
4.6. Miscellaneous genes 
SP is one of the neurotransmitters that appears in the mouse vomeronasal 
organ and it is suggested to be a trophic factor for the development of the vomeronasal 
glands in the cavernous tissue (Nagahara et al., 1995). A distinct sex-related 
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difference in the anterior pituitary level of SP-like immunoreactivity (SP-LI) in adult 
rats was found. The anterior pituitaries of male rats contained a higher concentration 
of SP-LI than those of females. It is also proposed that neonatal exposure to 
testosterone plays a critical role in the sexual differentiation of the SP level in rat 
anterior pituitary (Yoshikawa and Hong, 1983). Whether a similar case appears in its 
expression in OB is examined in this study? From the results, no treatment effect 
including sex-related difference in SP gene expression was found in the OB. It may 
indicate that the expression of SP gene is not sexually dimorphic in the developing OB. 
Certainly, it is still possible that this treatment effect can only be observed in the level 
of gene translation. Even though it is found that SP upregulates the expression of 
aromatase via the activation of protein kinase C (Abe-Dohmae et al., 1996)，No such 
correlation between the transcription of these two genes are evidenced in this study 
(see Fig. 3.7 and Fig. 3.21). 
Expression of GnRH gene is the other gene we have investigated in this study. 
As mentioned earlier, KS is an inherited disorder defined by the association of 
hypogonadotropic hypogonadism and anosmia (Rugarli and Ballabio，1997). 
Hypogonadism in KS is due to a reduced secretion of GnRH by the hypothalamus and 
the loss of the sense of smell in KS patient is due to an abnormality in olfactory system 
development. In the absence of clues to explain why hypogonadotropic hypogonadism 
and anosmia were consistently associated in this disease. The pathogenesis of KS has 
long remained unknown. In 1989, Wray and colleagues found that the neurons 
secreting GnRH share the same development origin with the olfactory neurons and 
follow the same migration pathway of olfactory axons (Wray et al., 1989). Both 
GnRH and olfactory neurons are found in the olfactory placode. During development, 
the GnRH neurons migrate along the olfactory nerves and through the olfactory bulbs, 
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to reach their definitive location in the hypothalamus. Fig. 4.3 compares the olfactory 
bulbs under normal development and KS. In normal individuals axons of ON traverse 
the CP to reach the olfactory bulb. Within the GL of the bulb, they make synapses with 
dendrites of MC whose axons will form the OT. A tentative model is proposed in 
which the KAL protein (shaded area) is secreted by the mitral cells and is required in 
the glomerular layer for the establishment/maintenance of proper interactions with 
olfactory axons. In KS, KAL protein (a secreted protein with an adhesive or 
antiadhesive function) is absent. The olfactory axons therefore cannot interact 
properly with their target and ending their migration between the CP and the forebrain. 
The migration defect of GnRH neurons in KS would be a secondary effect caused by 
lack of contact between olfactory nerves and forebrain, resulting in the absence of a 
migration route. 
Olfactory \ 麵麵縫議 buib Z 
I 
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Olfactory epithelium 
Normal Kallmann's syndrome 
Fig 4.3. A model for KAL function and KS pathogenesis. OT-olfactory tract; MC-mitral cells; 
GL-glomerular layer; CP-cribriform plate; ON-olfactory neurons (Modified from Rugarli and 
Ballabio, 1997). 
114 
In present study, the development profile of the GnRH gene transcription 
during the development of the rat OB is investigated. Refer to our results, the GnRH 
gene is transcripted exclusively from day 2 to day 5，but its transcription reduces 
gradually from day 10 to day 20 and remains relatively low thereafter. The up-
regulation of GnRH gene transcription at day 5 may be important for the migration of 
the GnRH neurons from the olfactory placode to the hypothalamus. The later 
reduction of its expression may be due to the maturation of the GnRH neurons and 
most of the GnRH neurons have migrated to the hypothalamus. Overall, the 
transcription of GnRH gene is age dependent only but not sex dependent and no 
treatment effect can be found. As indicated in Fig. 3.22，TP-treatment enhances its 
expression in female at day 2 but suppresses it at day 5，it makes the interaction effect 
significant. Later in the development, differences can be found in the GnRH 
expression between control female and TP-treated female rats (F/TPF), which makes 
the treatment effect significant at the level ofp<0.05. 
The olfactory bulb is an area where mRNA of all members of the mGluR family 
appear. It is known that the mGluRs mediate the transduction of the olfactory signals 
and the formation of olfactory memory (Kaba et al., 1994). The expression ofmGluRs 
at dendrodendritic synapses would seem to be a strong clue to the importance of these 
molecules in olfactory information processing. Such a role in olfactory memory has 
been demonstrated for mGluR2} which shows high expression in granule cells of the 
accessory olfactory bulb. This region is specialized for the processing of pheromone 
signals, most clearly demonstrated by the olfactory block to pregnancy known as the 
Bruce effect (Kinzie et al., 1998). Actually, Nakanishi and colleagues (1994) 
demonstrated the presence of mGluR2 at the presynaptic site of granule cells and 
modulates inhibitory GABA transmission from granule cells to mitral cells (Nakanishi 
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et al., 1994). This mechanism was considered to relieve a mitral cell from GABAergic 
inhibition and furthermore to be involved in lateral inhibition of surrounding mitral cells 
and thus enhancing the signal/noise ratio of olfactory sensation (Hayashi, 1999). From 
our results, mGluR2 gene expression is found to be increased from day 2 to day 15， 
which is the maximum. It then falls and remains low in the later development. It 
seems that its expression may play an important role in the early development of the 
OB. There is, however, no significant treatment effect in its expression in the overall 
development (Table 3.21). It should be noticed that at day 2, the TP-treatment greatly 
increased the expression of mGluR2 compared with those of the control female rats. 
While at day 5，it greatly suppressed the expression of this gene in the treated rats. As 
a result, significant interaction effects are observed (Table 3.21). Among the vehicle 
treated rats, there is a progressive increase if this gene expression to the peak levels at 
day 10 & 15. It probably may indicate the importance of this receptor before the 
pubertal stage. 
The IGFs are peptides that regulate growth and differentiation. They are 
synthesized in most tissues and act locally in a paracrine manner through specific 
receptors (Sara and Hall, 1990). Their activity may be modulated through interaction 
with a family of IGFBPs. IGFBPs are supposed to have a potential role in transporting 
and targeting IGFs to their receptors (Werther et al., 1998)，however the in vivo 
functions of IGFBPs remain unclear (Green et al, 1994). Especially, the regulation of 
expression of the IGFBPs has not been fully determined (Russo et al., 1994). IGF-1 
and its receptors are highly expressed in the olfactory bulb and IGF-1 is known to 
complex with IGFBP-2 (Brooker et al., 2000) and may either facilitate or inhibit IGF-1 
activity depending on their concentration (Arai et al., 1996). We have examined the 
expression profile of IGFBP-2 gene in this study. It is found that the IGFBP-2 gene 
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expression increases during the neonatal period, i.e. day 2 to day 10，then falls from 
day 15 and remains a constant level from day 20 to day 45 (Fig 3.24). From 
immunohistochemical evidences on IGFBP-2 expression in the newborn rat OB, an 
increase of IGFBP-2 expression in glial cells of the glomerular cell layer was reported 
(Russo et al., 1994). Comparing with our results, its does express in newborn at OB 
and increases in the early development, this seems that it may play a role in the early 
differentiation and development of the neurons. On the other hand, IGF-1 are known 
to prevent neuronal apoptosis by phosphorylation of BAD, which prevents BAD from 
binding the Bcl-2 protein, and inhibits the ability of Bcl-2 to initiate mitochondria 
changes required for apoptosis (Leventhal et al., 1999). Examination on the 
expressions of bad and bcl- XL gene are interesting to know more about this control 
mechanism. Correlation between the expression patterns of IGFBP-2 and bcl-2a gene 
is not found in this study. 
So far, most of the gene expressions we have investigated are age dependent, 
however, not all of them show a distinct pattern. On the other hand, sex and treatment 
effects are not always found. In some cases, the TP-treatment has significant effects 
on gene transcriptions during the development. The development of olfactory bulb is a 
part of the complicate process of CNS development, which involved many changes in 
gene expressions. 
In this study, we are examining the gene expression patterns in the OB as a 
whole. It is hard to tell which groups of cell are the genes expressed in. It is more 
ideal to localize the gene transcriptions in particular groups of cell. In-situ 
hybridization is a useful approach to focus on the localization of the transcription of 
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various genes. Combining and comparing the results of the present study and that of 
the in-situ hybridization study could find a more complete picture. 
In the present study, we have investigated the transcriptions of different genes 
in the developing OB. The control of the development, however, can also be gene 
translation dependent. Protein synthesis is one step that further controls the 
development. The gene transcription is not always correlate with its translation 
(Alberts et al., 1983). In order to understand the gene regulation on the development 
of OB, it is, therefore, also necessary to examine the translation of these genes using 
both Western blot and immunohistochemistry to tackle this problem. 
By combining immunohistochemistry, flow cytometry and cell sorting 
technology, one can even select specific types of cells from enzyme dissociated OB. 
Examination on the transcription of genes in specific cell types can further our 
knowledge on this theme. 
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